<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosntds</journal-id>
      <journal-title-group>
        <journal-title>PLoS Neglected Tropical Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1935-2735</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">PNTD-D-12-00752</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pntd.0002020</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Infectious diseases</subject>
            <subj-group>
              <subject>Sexually transmitted diseases</subject>
              <subj-group>
                <subject>Chlamydia</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Ophthalmology</subject>
            <subj-group>
              <subject>Eye infections</subject>
              <subject>Trachoma</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Infectious Diseases</subject>
          <subject>Ophthalmology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Trachoma: Protective and Pathogenic Ocular Immune Responses to <italic>Chlamydia trachomatis</italic></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Hu</surname>
            <given-names>Victor H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Holland</surname>
            <given-names>Martin J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Burton</surname>
            <given-names>Matthew J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>Kilimanjaro Christian Medical Centre, Moshi, Tanzania</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Lietman</surname>
            <given-names>Thomas M.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>University of California San Francisco, United States of America</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">victor.hu@lshtm.ac.uk</email></corresp>
        <fn fn-type="conflict">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <month>2</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>2</month>
        <year>2013</year>
      </pub-date>
      <volume>7</volume>
      <issue>2</issue>
      <elocation-id>e2020</elocation-id>
      <permissions>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Hu et al</copyright-holder>
        <license xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Trachoma, caused by <italic>Chlamydia trachomatis</italic> (<italic>Ct</italic>), is the leading infectious blinding disease worldwide. Chronic conjunctival inflammation develops in childhood and leads to eyelid scarring and blindness in adulthood. The immune response to <italic>Ct</italic> provides only partial protection against re-infection, which can be frequent. Moreover, the immune response is central to the development of scarring pathology, leading to loss of vision. Here we review the current literature on both protective and pathological immune responses in trachoma. The resolution of <italic>Ct</italic> infection in animal models is IFNγ-dependent, involving Th1 cells, but whether this is the case in human ocular infection still needs to be confirmed. An increasing number of studies indicate that innate immune responses arising from the epithelium and other innate immune cells, along with changes in matrix metalloproteinase activity, are important in the development of tissue damage and scarring. Current trachoma control measures, which are centred on repeated mass antibiotic treatment of populations, are logistically challenging and have the potential to drive antimicrobial resistance. A trachoma vaccine would offer significant advantages. However, limited understanding of the mechanisms of both protective immunity and immunopathology to <italic>Ct</italic> remain barriers to vaccine development.</p>
      </abstract>
      <funding-group>
        <funding-statement>This study was funded by grants from the Wellcome Trust (080741/Z/06/Z and 079246/Z/06/Z) and by a grant for the British Council for the Prevention of Blindness. VHH is supported by a fellowship grant from the British Council for the Prevention of Blindness (Barrie Jones Fellowship). The funders had no part in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="13"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Trachoma results from infection of the conjunctiva with <italic>Chlamydia trachomatis</italic> (<italic>Ct</italic>) and is the commonest infectious cause of blindness worldwide. The World Health Organization (WHO) estimates that at least 1.3 million people are blind from trachoma and 40 million have active disease; it is also part of the Neglected Tropical Diseases Programme <xref ref-type="bibr" rid="pntd.0002020-Resnikoff1">[1]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Mariotti1">[2]</xref>. It is caused by <italic>Ct</italic> serovars A to C and is generally found in poor, rural areas in less developed countries.</p>
      <p>Genital tract <italic>Ct</italic> infection, the commonest bacterial sexually transmitted disease worldwide, infecting 90 million people each year, is caused by serovars D to K <xref ref-type="bibr" rid="pntd.0002020-World1">[3]</xref>. The ocular and genital strains are strictly differentiated with ocular strains lacking tryptophan synthase function <xref ref-type="bibr" rid="pntd.0002020-Caldwell1">[4]</xref>. Both ocular and genital infections produce inflammatory reactions, which are often asymptomatic, leading to scarring complications with significant morbidity in a subset of those infected. The WHO recommends the SAFE Strategy for trachoma control: <underline>S</underline>urgery for trichiasis, mass <underline>A</underline>ntibiotic distribution to treat infection, improved <underline>F</underline>acial hygiene, and <underline>E</underline>nvironmental improvements to interrupt <italic>Ct</italic> transmission <xref ref-type="bibr" rid="pntd.0002020-WHO1">[5]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Emerson1">[7]</xref>. While implementation of this strategy appears to be effective in reducing active ocular infection with <italic>Ct</italic>, successfully carrying it out on a programmatic level can be challenging in the areas where trachoma is found, and the long-term effect on the scarring stages of trachoma is unknown.</p>
      <p>The immune response to <italic>Ct</italic> provides incomplete protection and is known to be important in the development of tissue damage and sequelae including blinding complications. However, protective immune responses and disease pathogenesis in trachoma remain poorly understood. The “immunological paradigm” suggested that disease pathology is a result of cell-mediated immune (CMI) responses against specific chlamydial antigens. The “cellular paradigm” states that infected epithelial cell responses drive pathology through the release of various mediators, and this is supported by recent studies in humans and animal models, which have highlighted the importance of an innate immune response in active and scarring trachoma.</p>
      <p>This article reviews the literature on immunity and immunopathogenesis in trachoma. Human studies of the pathology, immune response, and immunopathogenesis in trachoma are comprehensively summarised. Whilst focusing on these human studies of ocular <italic>Ct</italic> infection, we also draw on relevant studies of genital tract infection and animal models. Ocular infection of nonhuman primates leads to a self-limiting follicular conjunctivitis after a single innoculum, and chronic inflammation, conjunctival scarring, and trichiasis with repeated inoculations <xref ref-type="bibr" rid="pntd.0002020-Taylor1">[8]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Taylor4">[12]</xref>. Such a response is similar to that seen in humans, and this model has useful parallels for human disease <xref ref-type="bibr" rid="pntd.0002020-TaylorRobinson1">[13]</xref>. Other animal models, often involving mice <xref ref-type="bibr" rid="pntd.0002020-Shah1">[14]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Ramsey1">[15]</xref> and guinea pigs <xref ref-type="bibr" rid="pntd.0002020-Lacy1">[16]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Treharne1">[17]</xref>, are limited by major differences in immune responses with humans <xref ref-type="bibr" rid="pntd.0002020-Mestas1">[18]</xref>. Additionally, they have usually relied on the use of other chlamydial species such as <italic>Chlamydia caviae</italic>, <italic>psittaci</italic>, or <italic>muridarum</italic>, which may be evolutionarily separated from <italic>Ct</italic> and are adapted to their respective hosts.</p>
    </sec>
    <sec id="s2" sec-type="methods">
      <title>Methods</title>
      <p>Ethical approval was not required for this review article. References were identified through searches of PubMed for articles published at any date, by use of the terms “trachoma” and “immunology,” “pathogenesis,” “pathology,” “scarring,” or “histology.” Articles resulting from these searches and relevant articles cited in those articles were reviewed. Articles published in English were included. Relevant human studies, which are the focus of this review, are summarised in Tables S1, S2, S3, S4, S5, S6 in Supporting Information S1.</p>
    </sec>
    <sec id="s3">
      <title>Clinical Features, Natural History, and Infection</title>
      <p>Infection with <italic>Ct</italic> causes chronic inflammation of the conjunctiva (conjunctivitis) or “active trachoma,” which is characterised by follicles (subepithelial collections of lymphoid cells appearing as small, yellow-white elevations) and papillae (engorgement of small vessels with inflammatory conjunctival thickening). Infection may be detected in the absence of clinical disease, and conversely, active disease may be present without detectable current <italic>Ct</italic> infection <xref ref-type="bibr" rid="pntd.0002020-Wright1">[19]</xref>. While this may appear paradoxical, there are a number of reasons to explain these findings, including how sensitive the diagnostic test is compared to the clinical examination, and also the kinetics of the disease <xref ref-type="bibr" rid="pntd.0002020-Wright1">[19]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Bailey1">[20]</xref>. These include a latent phase with infection before the onset of clinical signs and a recovery phase where infection has been cleared but clinical signs persist. Children experiencing repeated episodes of infection are at increased risk of subsequent conjunctival scarring, which causes in-turning of the eyelids (entropion) so that the eyelashes scratch the cornea (trichiasis). Eventually sight is lost as irreversible corneal opacification develops from a combination of insults, which compromise the ocular surface (trichiasis, dryness, secondary bacterial, or fungal infections). Clinical features are shown in <xref ref-type="fig" rid="pntd-0002020-g001">Figure 1</xref>. The scarring complications of trachoma usually develop slowly over many years. Several longitudinal studies support this pathway to blindness, although there is considerable variation in reported disease progression rates, possibly reflecting differences in both the natural history in different populations and in study methodology (<xref ref-type="table" rid="pntd-0002020-t001">Table 1</xref>).</p>
      <fig id="pntd-0002020-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pntd.0002020.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Clinical features and grades of trachoma.</title>
          <p>N, normal; TF, Trachomatous inflammation–follicular; TI, Trachomatous inflammation–intense; TS, trachomatous scarring; TT, trachomatous trichiasis; CO, corneal opacity.</p>
        </caption>
        <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pntd.0002020.g001" position="float" xlink:type="simple"/>
      </fig>
      <table-wrap id="pntd-0002020-t001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pntd.0002020.t001</object-id>
        <label>Table 1</label>
        <caption>
          <title>Summary of the incidence and progression rates of trachomatous scarring.</title>
        </caption>
        <alternatives>
          <graphic id="pntd-0002020-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pntd.0002020.t001" xlink:type="simple"/>
          <table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" rowspan="1" colspan="1">Progression Factor</td>
                <td align="left" rowspan="1" colspan="1">Sample Size</td>
                <td align="left" rowspan="1" colspan="1">Follow-Up Interval</td>
                <td align="left" rowspan="1" colspan="1">Rate</td>
                <td align="left" rowspan="1" colspan="1">Setting</td>
                <td align="left" rowspan="1" colspan="1">Prospective Design?</td>
                <td align="left" rowspan="1" colspan="1">Associated Factors</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Incident conjunctival scarring <xref ref-type="bibr" rid="pntd.0002020-Wolle1">[28]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Wolle2">[151]</xref></td>
                <td align="left" rowspan="1" colspan="1">367</td>
                <td align="left" rowspan="1" colspan="1">5 y</td>
                <td align="left" rowspan="1" colspan="1">20.4%</td>
                <td align="left" rowspan="1" colspan="1">Tanzania</td>
                <td align="left" rowspan="1" colspan="1">Yes</td>
                <td align="left" rowspan="1" colspan="1">In children &lt;10 y: active disease/persistent infection; female gender; age</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Incident conjunctival scarring <xref ref-type="bibr" rid="pntd.0002020-West2">[24]</xref></td>
                <td align="left" rowspan="1" colspan="1">236 (age &lt;7 y)</td>
                <td align="left" rowspan="1" colspan="1">7 y</td>
                <td align="left" rowspan="1" colspan="1">29.2% versus 9.6%</td>
                <td align="left" rowspan="1" colspan="1">Tanzania</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">Higher rate was in children with severe-constant active disease; female gender; age</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Worsening of conjunctival scarring <xref ref-type="bibr" rid="pntd.0002020-Wolle2">[151]</xref></td>
                <td align="left" rowspan="1" colspan="1">85</td>
                <td align="left" rowspan="1" colspan="1">5 y</td>
                <td align="left" rowspan="1" colspan="1">47.1%</td>
                <td align="left" rowspan="1" colspan="1">Tanzania</td>
                <td align="left" rowspan="1" colspan="1">Yes</td>
                <td align="left" rowspan="1" colspan="1">Not specified</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Worsening of conjunctival scarring <xref ref-type="bibr" rid="pntd.0002020-Dawson1">[25]</xref></td>
                <td align="left" rowspan="1" colspan="1">213<xref ref-type="table-fn" rid="nt101">a</xref></td>
                <td align="left" rowspan="1" colspan="1">14 y</td>
                <td align="left" rowspan="1" colspan="1">68.5%</td>
                <td align="left" rowspan="1" colspan="1">Tunisia</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">Active disease; household density</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">From conjunctival scarring to trichiasis <xref ref-type="bibr" rid="pntd.0002020-Munoz1">[26]</xref></td>
                <td align="left" rowspan="1" colspan="1">523 (all women)</td>
                <td align="left" rowspan="1" colspan="1">7 y</td>
                <td align="left" rowspan="1" colspan="1">9.2%</td>
                <td align="left" rowspan="1" colspan="1">Tanzania</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">Active disease; chlamydial infection; increasing age</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">From conjunctival scarring to trichiasis <xref ref-type="bibr" rid="pntd.0002020-Bowman1">[152]</xref></td>
                <td align="left" rowspan="1" colspan="1">297</td>
                <td align="left" rowspan="1" colspan="1">12 y</td>
                <td align="left" rowspan="1" colspan="1">6.4%</td>
                <td align="left" rowspan="1" colspan="1">Gambia</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">Mandinka ethnicity</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">From conjunctival scarring to trichiasis <xref ref-type="bibr" rid="pntd.0002020-Burton1">[27]</xref></td>
                <td align="left" rowspan="1" colspan="1">4,898</td>
                <td align="left" rowspan="1" colspan="1">5 y</td>
                <td align="left" rowspan="1" colspan="1">3.2%–15.1%</td>
                <td align="left" rowspan="1" colspan="1">Tanzania</td>
                <td align="left" rowspan="1" colspan="1">No<xref ref-type="table-fn" rid="nt102">b</xref></td>
                <td align="left" rowspan="1" colspan="1">Increasing age</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">From minor to major trichiasis <xref ref-type="bibr" rid="pntd.0002020-Bowman2">[153]</xref></td>
                <td align="left" rowspan="1" colspan="1">55</td>
                <td align="left" rowspan="1" colspan="1">1 y</td>
                <td align="left" rowspan="1" colspan="1">33%</td>
                <td align="left" rowspan="1" colspan="1">Gambia</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">None mentioned</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">From minor to major trichiasis <xref ref-type="bibr" rid="pntd.0002020-Burton1">[27]</xref></td>
                <td align="left" rowspan="1" colspan="1">75</td>
                <td align="left" rowspan="1" colspan="1">4 y</td>
                <td align="left" rowspan="1" colspan="1">37%</td>
                <td align="left" rowspan="1" colspan="1">Gambia</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">Conjunctival inflammation</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">From unilateral to bilateral trichiasis <xref ref-type="bibr" rid="pntd.0002020-Bowman2">[153]</xref></td>
                <td align="left" rowspan="1" colspan="1">46</td>
                <td align="left" rowspan="1" colspan="1">1 y</td>
                <td align="left" rowspan="1" colspan="1">46%</td>
                <td align="left" rowspan="1" colspan="1">Gambia</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">Baseline pannus; hot ash as an aid to epilation</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">From conjunctival scarring +/− trichiasis to corneal scarring <xref ref-type="bibr" rid="pntd.0002020-Bowman1">[152]</xref></td>
                <td align="left" rowspan="1" colspan="1">302</td>
                <td align="left" rowspan="1" colspan="1">12 y</td>
                <td align="left" rowspan="1" colspan="1">6.0%</td>
                <td align="left" rowspan="1" colspan="1">Gambia</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">Baseline trichiasis</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">From trichiasis to corneal scarring <xref ref-type="bibr" rid="pntd.0002020-Burton1">[27]</xref></td>
                <td align="left" rowspan="1" colspan="1">211</td>
                <td align="left" rowspan="1" colspan="1">4 y</td>
                <td align="left" rowspan="1" colspan="1">7.6%</td>
                <td align="left" rowspan="1" colspan="1">Gambia</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">Increasing trichiasis severity; conjunctival inflammation</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">From trichiasis to corneal opacity <xref ref-type="bibr" rid="pntd.0002020-Munoz2">[154]</xref></td>
                <td align="left" rowspan="1" colspan="1">4,898</td>
                <td align="left" rowspan="1" colspan="1">10 y</td>
                <td align="left" rowspan="1" colspan="1">27.2%–53.5%</td>
                <td align="left" rowspan="1" colspan="1">Tanzania</td>
                <td align="left" rowspan="1" colspan="1">No<xref ref-type="table-fn" rid="nt102">b</xref></td>
                <td align="left" rowspan="1" colspan="1">Increasing age</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Worsening of corneal scarring <xref ref-type="bibr" rid="pntd.0002020-Bowman2">[153]</xref></td>
                <td align="left" rowspan="1" colspan="1">96</td>
                <td align="left" rowspan="1" colspan="1">1 y</td>
                <td align="left" rowspan="1" colspan="1">34%</td>
                <td align="left" rowspan="1" colspan="1">Gambia</td>
                <td align="left" rowspan="1" colspan="1">No</td>
                <td align="left" rowspan="1" colspan="1">Conjunctival inflammation; bacterial growth</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="nt101">
            <label>a</label>
            <p>Including 82 people with no scarring at baseline.</p>
          </fn>
          <fn id="nt102">
            <label>b</label>
            <p>Estimated incidence rates based on age-specific prevalence of scarring, trichiasis, and corneal opacity among women.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>A key question is why only a minority of people living in trachoma endemic regions develop severe scarring complications. It is likely that the answer to this is a complex interaction between the individual's lifetime burden of infection and their local immune response. Risk factors for trachoma have been extensively reviewed elsewhere <xref ref-type="bibr" rid="pntd.0002020-Wright1">[19]</xref>, <xref ref-type="bibr" rid="pntd.0002020-West1">[21]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Hu1">[23]</xref> and include poor facial hygiene with unwashed ocular/nasal secretions, crowded living conditions, flies (which act as a vector for the disease), and migration between communities. Severe, persistent, or recurrent conjunctival inflammation is strongly associated with the risk of scarring complications <xref ref-type="bibr" rid="pntd.0002020-West2">[24]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Wolle1">[28]</xref>. Females are at increased risk of conjunctival scarring and trichiasis, possibly from greater lifetime <italic>Ct</italic> exposure through close contact with children <xref ref-type="bibr" rid="pntd.0002020-West1">[21]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Congdon1">[29]</xref>. In regions where trachoma is highly endemic, scarring sequelae are more common and occur at a younger age <xref ref-type="bibr" rid="pntd.0002020-King1">[30]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Ngondi1">[31]</xref>. There is good evidence that the immune response to <italic>Ct</italic> is partly determined by host genetic variations, with several studies from different populations having identified genetic polymorphisms related to immune system function that are associated with trachomatous scarring. These include polymorphisms in interferon-γ (IFNγ), tumour necrosis factor-α, and matrix metalloproteinase (MMP) 9 (Table S1) and indicate the importance of host immunogenetic variations in modifying the risk of developing blinding disease.</p>
      <p>Trachoma was initially thought to result from a single episode of infection <xref ref-type="bibr" rid="pntd.0002020-TaylorHR1">[32]</xref>. However, the importance of repeated re-infection in the pathogenesis of scarring disease is now supported by various lines of investigation: animal models require repeated inoculation to induce disease <xref ref-type="bibr" rid="pntd.0002020-Taylor2">[9]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Grayston1">[10]</xref>, absence of scarring following a single inoculation in human volunteer studies <xref ref-type="bibr" rid="pntd.0002020-TaylorHR1">[32]</xref>, and cohort studies from trachoma-endemic areas demonstrating repeated infection <xref ref-type="bibr" rid="pntd.0002020-Bailey1">[20]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Wolle1">[28]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Faal1">[33]</xref>. However, in vitro studies have shown that persistent, nonreplicating forms of <italic>Ct</italic> develop in response to various stress stimuli (penicillin, IFNγ, and iron or nutrient depletion) <xref ref-type="bibr" rid="pntd.0002020-Wyrick1">[34]</xref>. The relevance of these findings to human infection is not known. There is very limited in vivo evidence for persistent ocular infection <xref ref-type="bibr" rid="pntd.0002020-Smith1">[35]</xref>. An important observation about <italic>Ct</italic> infection and ocular disease is that infection is infrequently detected in older adults, who are the group in which progressive scarring and blinding complications usually develop <xref ref-type="bibr" rid="pntd.0002020-Burton1">[27]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton2">[36]</xref>–<xref ref-type="bibr" rid="pntd.0002020-West3">[38]</xref>. This is partly explained by the shorter duration of infection with increasing age <xref ref-type="bibr" rid="pntd.0002020-Bailey2">[39]</xref>. However, other factors may also be important in scarred conjunctiva, such as nonchlamydial bacterial infection (discussed below).</p>
    </sec>
    <sec id="s4">
      <title>Histopathology</title>
      <p>Histological examination of conjunctival biopsy samples from subjects with trachoma has given some insights into the disease process (Table S2). However, interpretation of studies conducted to date is limited by the relatively small sample sizes involved and few or no control participants. Comparison with nontrachomatous subjects is essential to establish background conjunctival morphology and cellular compositions in these trachoma-endemic areas, as this may differ markedly from those populations where trachoma is not endemic.</p>
      <sec id="s4a">
        <title>Active Disease</title>
        <p>Histological studies of conjunctival biopsies from children with active trachoma found mild to moderate epithelial hyperplasia with a mixed inflammatory infiltrate consisting of many macrophages with some T cells and polymorphonuclear leucocytes (Table S2) <xref ref-type="bibr" rid="pntd.0002020-Abrahams1">[40]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Guzey1">[42]</xref>. Dendritic cells are seen in the deeper epithelium and underlying stroma. Plasma cells form a band directly beneath the epithelium and around accessory lacrimal glands. Lymphoid follicles, the clinical and pathological hallmark of active trachoma, are found in the stroma (<xref ref-type="fig" rid="pntd-0002020-g002">Figure 2</xref>). In children these consist mainly of B cells with some macrophages and T cells and are surrounded with a lymphocytic mantle. Around the follicle, a diffuse infiltrate consisting of a mixed population of leucocytes (T cells, neutrophils, macrophages, mast cells, and eosinophils) is seen. Schematic diagrams of normal conjunctiva and active disease are shown in <xref ref-type="fig" rid="pntd-0002020-g003">Figure 3</xref>.</p>
        <fig id="pntd-0002020-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pntd.0002020.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Histological section of the conjunctiva from a child with active trachoma.</title>
            <p>A subepithelial follicle is seen. Kindly provided by Professor A. El-Asrar, King Saud University.</p>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pntd.0002020.g002" position="float" xlink:type="simple"/>
        </fig>
        <fig id="pntd-0002020-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pntd.0002020.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Schemas of normal conjunctiva, active trachomatous disease, and trachomatous scarring.</title>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pntd.0002020.g003" position="float" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s4b">
        <title>Scarring Disease</title>
        <p>Adults with conjunctival scarring have an epithelium that may show either squamous metaplasia or atrophy with focally denuded areas replaced by fibrinous exudate and cellular debris (<xref ref-type="fig" rid="pntd-0002020-g004">Figure 4</xref>) <xref ref-type="bibr" rid="pntd.0002020-Guzey1">[42]</xref>, <xref ref-type="bibr" rid="pntd.0002020-alRajhi1">[43]</xref>. A chronic inflammatory cell infiltrate is found, most marked in the substantia propria with lymphocytes predominating <xref ref-type="bibr" rid="pntd.0002020-Abrahams1">[40]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Reacher1">[44]</xref>. CD4+ and CD8+ T cells are present, and these generally outnumber B cells. Follicles may be seen histologically in very inflamed subjects, even when absent clinically; these contain monocytes, macrophages, and plasma cells but lack the germinal centres or centrally located B cells seen in follicles of children. Underneath the epithelium, the stroma is replaced by abnormal, compact, thick, and mostly avascular scar tissue <xref ref-type="bibr" rid="pntd.0002020-alRajhi1">[43]</xref>. This subepithelial fibrous membrane has fibres parallel to the surface epithelium and is firmly adherent to the tarsal plate (<xref ref-type="fig" rid="pntd-0002020-g003">Figure 3</xref>).</p>
        <fig id="pntd-0002020-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pntd.0002020.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Histological sections of healthy conjunctiva and trachomatous scarring.</title>
            <p>(Top) Healthy. (Middle and bottom) Scarred, note disruption of the epithelial and connective tissue morphology, and an increased inflammatory cells.</p>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pntd.0002020.g004" position="float" xlink:type="simple"/>
        </fig>
      </sec>
    </sec>
    <sec id="s5">
      <title>Resolution of <italic>Ct</italic> Infection</title>
      <p>A number of immune-mediated responses have been demonstrated to <italic>Ct</italic> infection that are thought to be important in clearing infection. The area requires further clarification, however, with many of these responses yet to be unequivocally associated with resolution of infection in human <italic>Ct</italic> infection.</p>
      <sec id="s5a">
        <title>Epithelial Cells Mount a Pro-Inflammatory and Chemotactic Response</title>
        <p>Several in vitro studies of <italic>Ct</italic>-infected epithelial cell lines have found that this infection provokes pro-inflammatory responses with epithelial cells producing inflammatory and chemotactic cytokines such as interleukin-6 (IL-6), IL-8, growth-regulated oncogene α (GROα), and granulocyte macrophage colony-stimulating factor (GM-CSF) <xref ref-type="bibr" rid="pntd.0002020-Rasmussen1">[45]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Johnson1">[47]</xref>. The secretion of these factors was prolonged and required synthesis of chlamydial proteins. In contrast, other bacterial species provoked a rapid but transient cytokine induction <xref ref-type="bibr" rid="pntd.0002020-Rasmussen1">[45]</xref>.</p>
        <p>Human studies are consistent with the epithelium-producing pro-inflammatory factors constituting an initial innate response to <italic>Ct</italic>. Immunohistochemistry of conjunctival epithelium from children with active trachoma has shown IL-1 expression <xref ref-type="bibr" rid="pntd.0002020-AbuelAsrar1">[48]</xref>. Gene expression studies on conjunctival surface swab samples find enriched expression of multiple pro-inflammatory/chemotactic factors (Table S3). In active trachoma, the epithelium shows increased Major Histocompatibility Complex (MHC) class I expression (found at a lower level in normal conjunctiva) and induction of MHC class II (not normally found at this site) <xref ref-type="bibr" rid="pntd.0002020-elAsrar1">[41]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Mabey1">[49]</xref>. There is also evidence for natural killer (NK) cell and neutrophil recruitment and activation in active disease/infection as part of an acute inflammatory response <xref ref-type="bibr" rid="pntd.0002020-Lacy1">[16]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Natividad1">[50]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Gall1">[51]</xref>.</p>
      </sec>
      <sec id="s5b">
        <title>Importance of a CMI Response and IFNγ Production</title>
        <p>The results of animal studies of genital chlamydial infection suggest that resolution of infection is dependent on a Type-1 CD4+ T-helper lymphocyte (Th1) response-mediated primarily through IFNγ. Congenitally athymic (nude) mice are unable to clear <italic>C. muridarum</italic> genital tract infection <xref ref-type="bibr" rid="pntd.0002020-Rank1">[52]</xref>. However, adoptive transfer to nude mice of CD4+ or CD8+ T cells derived from normal mice previously infected with <italic>C. muridarum</italic> resolved the infection <xref ref-type="bibr" rid="pntd.0002020-Ramsey2">[53]</xref>. The CD4+-enriched cell line was much more efficient at clearing infection. However, recent murine studies using <italic>Ct</italic> instead of <italic>C. muridarum</italic> as the infectious agent did not find that the absence of CD4+ cells altered the course of infection and limitations of animal models of <italic>Ct</italic> infection need to be acknowledged <xref ref-type="bibr" rid="pntd.0002020-Morrison1">[54]</xref>. Although CD8+ T cells can help resolve infection, they seem less important in animal models, as they were not an absolute requirement for clearing infection <xref ref-type="bibr" rid="pntd.0002020-Brunham1">[55]</xref>.</p>
        <p>IFNγ is produced by several cell types including Th1 lymphocytes, CD8+ cytotoxic T lymphocytes (CTLs), and NK cells. The production of IFNγ characterises the Th1 response and has several antichlamydial actions, which probably play a central role in clearing infection. IFNγ induces indoleamine-2,3-dioxygenase (IDO) expression, which lowers the intracellular pool of the essential amino acid tryptophan, which is necessary for chlamydial metabolism <xref ref-type="bibr" rid="pntd.0002020-Thomas1">[56]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Rapoza1">[57]</xref>. IFNγ can also up-regulate inducible nitric oxide synthase (iNOS), which may help control <italic>Ct</italic> and protect against chronic sequelae in murine models <xref ref-type="bibr" rid="pntd.0002020-Ramsey3">[58]</xref>. In vitro, chlamydial growth can also be limited by IFNγ-mediated intracellular iron depletion <xref ref-type="bibr" rid="pntd.0002020-Igietseme1">[59]</xref>.</p>
        <p>Several human studies point to the importance of the CMI response to ocular <italic>Ct</italic> infection, although direct longitudinal evidence that resolution is IFNγ-dependent is limited. Biopsies from children with active trachoma show heavy cellular infiltrates with both CD4+ and CD8+ lymphocytes (Table S2) <xref ref-type="bibr" rid="pntd.0002020-elAsrar1">[41]</xref>. Children who resolved active disease (associated with infection) had stronger peripheral blood lymphoproliferative responses to <italic>Ct</italic> antigens compared to children with persistent disease (Table S4) <xref ref-type="bibr" rid="pntd.0002020-Bailey3">[60]</xref>. Gene expression studies have shown increased expression of <italic>IFNγ</italic>, <italic>IL12p40</italic>, <italic>Perforin</italic>, <italic>IDO</italic>, <italic>IL-4</italic>, <italic>IL-10</italic>, and forkhead box p3 (<italic>FOXP3</italic>) in infection and/or disease, with levels generally being highest if both were present (Table S3) <xref ref-type="bibr" rid="pntd.0002020-Faal1">[33]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Natividad1">[50]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton4">[61]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Faal2">[62]</xref>. Increased expression of <italic>IFNγ</italic>, <italic>IL-10</italic>, and <italic>FOXP3</italic> has been associated with longer episodes of infection <xref ref-type="bibr" rid="pntd.0002020-Holland1">[63]</xref>. A recent study using <italic>Ct</italic> elementary bodies (EBs) to stimulate PBMC from individuals exposed to ocular infection showed that cells with a classical NK cell phenotype (CD3-CD56+) were an additional major source of IFNγ <xref ref-type="bibr" rid="pntd.0002020-Gall1">[51]</xref>.</p>
      </sec>
    </sec>
    <sec id="s6">
      <title>Protective Immunity to <italic>Ct</italic></title>
      <p>Human volunteer studies of ocular <italic>Ct</italic> infection have provided some evidence that a partial, protective immune response develops <xref ref-type="bibr" rid="pntd.0002020-Jawetz1">[64]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Tarizzo1">[66]</xref>. Conjunctival inoculation with <italic>Ct</italic> led to a characteristic follicular/papillary conjunctivitis in nearly all volunteers after 2–14 d. However, when previously infected individuals were rechallenged with the same serovar, there was an attenuated clinical response with reduced re-isolation rates. This apparent immunity to re-infection was serovar-specific: if a different serovar was used, then disease and infection levels were similar to the primary infection. Presumed complete immunity after primary infection, in which no clinical signs developed and the organism was never detected, despite multiple rechallenge inoculations, was rare. Despite the concerns over the induction of presumed delayed-type hypersensitivity (DTH), the trachoma vaccine trials in the 1960s did demonstrate short-term, serovar-specific immunity could be induced <xref ref-type="bibr" rid="pntd.0002020-Nichols1">[67]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Sowa1">[68]</xref>. Trachoma models in nonhuman primates also showed that, after recovery from a primary infection, on secondary challenge there was less severe disease that resolved more rapidly <xref ref-type="bibr" rid="pntd.0002020-Taylor2">[9]</xref>. With regular weekly re-inoculations, it also became progressively more difficult to detect the organism, suggesting the development of protective immunity. The human studies discussed above were conducted over 40 years ago and need to be interpreted in that context. Ethical considerations, however, limit contemporary studies to being of an observational design.</p>
      <p>A longitudinal study in which a cohort from a trachoma endemic population was regularly assessed for disease and infection found the duration of both shortened considerably with increasing age <xref ref-type="bibr" rid="pntd.0002020-Bailey2">[39]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Grassly1">[69]</xref>. This is thought to be the result of an increasingly effective protective immune response developing with repeated exposure to <italic>Ct</italic>, although other factors could also have been important, such as behavioural changes. Another study has shown that in 4- to 15-y-olds, there was evidence of age-related modulation of cytokine expression, with older individuals tending to have greater expression of IFNγ, IDO, and <italic>IL-10</italic> <xref ref-type="bibr" rid="pntd.0002020-Faal2">[62]</xref>. The clinical manifestations also appeared to be modulated: adults experienced short bursts of intense disease and children more prolonged episodes of follicular disease <xref ref-type="bibr" rid="pntd.0002020-Bailey2">[39]</xref>.</p>
      <p>Acquired T-cell–dependent CMI responses, as outlined above, probably contribute to protection against or more rapid resolution of re-infection, although direct evidence for this from human trachoma studies is limited. Fading immunity in animal models is correlated with a reduction in CD4+ T cells, which leave the genital tract following resolution of infection <xref ref-type="bibr" rid="pntd.0002020-Rank2">[70]</xref>. A study of the incidence of genital tract infection amongst sex workers in Nairobi, Kenya, found that IFNγ production by PBMC stimulated with cHsp60 was associated with reduced risk of re-infection compared to women without such responses <xref ref-type="bibr" rid="pntd.0002020-Cohen1">[71]</xref>.</p>
      <p>The importance of humoral immunity to <italic>Ct</italic> is unclear. Several human studies have detected antichlamydial antibodies in tear fluid and serum (Table S5). However, in a longitudinal study, antichlamydial IgG in tears from clinically normal individuals was associated with an increased incidence of subsequently developing clinically active trachoma <xref ref-type="bibr" rid="pntd.0002020-Bailey4">[72]</xref>. In contrast, there was an opposite (nonsignificant) trend with antichlamydial IgA. Individuals with conjunctival scarring have been found to have significantly higher plasma titres of antichlamydial IgG and lower titres of IgA compared with normal controls <xref ref-type="bibr" rid="pntd.0002020-Holland2">[73]</xref>.</p>
      <p>However, a consistent picture on the role of antibody in protection from trachoma has not emerged from these studies. What is clear is that the overall level of the antibody response can be a useful proxy of the lifetime exposure to ocular infection. Within the overall antibody response, a profile of specific antibodies directed against a limited number of individual antigens are associated with the presence or absence of clinical signs of disease <xref ref-type="bibr" rid="pntd.0002020-Lu1">[74]</xref>. However, how such antibodies mediate protection and pathology requires elucidation.</p>
      <p>Various animal models of genital tract infection have yielded a mixed pattern of results on the relative importance of the humoral response. Some have shown that B-cell–deficient mice can resolve a primary chlamydial infection and are only slightly delayed in clearing secondary infections, compared to control mice <xref ref-type="bibr" rid="pntd.0002020-Ramsey4">[75]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Su1">[76]</xref>. However, other studies found that B-cell–deficient mice that also had their CD4+ cells depleted were completely unable to control secondary infection, whereas mice depleted of CD4+ cells alone only showed slight delay in clearing secondary infection <xref ref-type="bibr" rid="pntd.0002020-Morrison2">[77]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Morrison3">[78]</xref>. In addition, transfer of monoclonal antibodies to <italic>Ct</italic> major outer membrane protein (MOMP) and LPS into B-cell–deficient, CD4+ T-cell–depleted mice restored the ability of these mice to control secondary infection <xref ref-type="bibr" rid="pntd.0002020-Morrison4">[79]</xref>. Antibodies to polymorphic membrane protein D (PmpD) have also been shown to be neutralising in vitro <xref ref-type="bibr" rid="pntd.0002020-Crane1">[80]</xref>. However, whether similar protective effects occur in human ocular infection is unknown.</p>
    </sec>
    <sec id="s7">
      <title>Immunopathogenesis of Trachoma</title>
      <p>In 1974 Silverstein proposed that tissue damage and scarring sequelae in trachoma are the result of a chronic, immunopathogenic response to an otherwise seemingly innocuous, superficial infection <xref ref-type="bibr" rid="pntd.0002020-Silverstein1">[81]</xref>. He observed that <italic>Ct</italic> infection itself is limited to a small minority of epithelial cells and is not particularly cytopathic, with cells accommodating large chlamydial inclusion bodies. The infection can be quite prolonged, suggesting that the immune response is relatively inefficient or that <italic>Ct</italic> is effective at avoiding immune responses. At the tissue level, the inflammatory infiltrate and subsequent scarring is in the conjunctival stroma, below the level of the epithelium, where the infection is located.</p>
      <p>A key clinical observation pointing to the immunopathogenic nature of trachoma is that visible conjunctival inflammation is frequently found in the absence of detectable <italic>Ct</italic> <xref ref-type="bibr" rid="pntd.0002020-Wright1">[19]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Bailey1">[20]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Faal1">[33]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton4">[61]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton5">[82]</xref>. In longitudinal studies, discrete episodes of active disease persist long after the associated initiating infectious episode has resolved <xref ref-type="bibr" rid="pntd.0002020-Bailey2">[39]</xref>. In one trachoma vaccine trial, the incidence of trachoma was higher in the vaccinated group and another reported a possible increase in disease severity <xref ref-type="bibr" rid="pntd.0002020-Sowa1">[68]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Woolridge1">[83]</xref>.</p>
      <p>Monkey models of <italic>Ct</italic> infection support the importance of immunopathology in trachoma <xref ref-type="bibr" rid="pntd.0002020-Taylor2">[9]</xref>. Treatment of infected animals with corticosteroids markedly reduced the inflammation, and in monkey vaccine studies, rechallenge was associated with more severe inflammatory disease and scarring complications <xref ref-type="bibr" rid="pntd.0002020-Taylor5">[84]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Wang1">[85]</xref>.</p>
      <p>Several theories for the pathogenesis and scarring caused by chlamydial infection have been proposed, none of which entirely explain the observed data. Stephens helpfully subdivided these into two broad paradigms: the “cellular paradigm” in which the response of the epithelial cell layer is central and sufficient to explain the pathology, and the “immunological paradigm” in which cell-mediated immunity causing either DTH or autoimmune mimicry explains disease pathology <xref ref-type="bibr" rid="pntd.0002020-Stephens1">[86]</xref>. These processes are not mutually exclusive and may both contribute.</p>
    </sec>
    <sec id="s8">
      <title>The “Immunological Paradigm” and Trachoma</title>
      <p>The “immunological paradigm” suggests that tissue damage and fibrosis in chlamydia-related disease results from CMI responses against specific chlamydial antigens <xref ref-type="bibr" rid="pntd.0002020-Darville1">[46]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Brunham1">[55]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Silverstein1">[81]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Stephens1">[86]</xref>. It argues that specific T-cell responses, which are important in clearing <italic>Ct</italic> infection, also cause collateral tissue damage. There are two major lines of investigation that have explored this hypothesis, which are discussed below.</p>
      <sec id="s8a">
        <title>DTH and cHsp60</title>
        <p>During early trachoma vaccine studies on nonhuman primates, it was observed that the disease phenotype could be more severe on rechallenge. This led the investigators to propose that a DTH reaction to chlamydial antigens was responsible for the disease <xref ref-type="bibr" rid="pntd.0002020-Grayston1">[10]</xref>. Subsequently, in a guinea pig model of ocular infection, a <italic>Ct</italic> antigen, extracted using the detergent triton X-100, was able to provoke an inflammatory reaction in animals previously infected with <italic>Ct</italic> <xref ref-type="bibr" rid="pntd.0002020-Watkins1">[87]</xref>. The active component was identified as the 57 kDa protein, cHsp60 <xref ref-type="bibr" rid="pntd.0002020-Morrison5">[88]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Morrison6">[89]</xref>. Similar experiments were conducted in cynomolgus monkeys, with comparable results <xref ref-type="bibr" rid="pntd.0002020-Taylor3">[11]</xref>. There was some concern that the conjunctival inflammatory response observed in these monkeys might have been partly provoked by the triton X-100 detergent itself, as repeated installation of the buffer alone also led to significant inflammation. However, when experiments were repeated with recombinant cHsp60, inflammation was provoked in guinea pig eyes and in the subcutaneous abdominal salpingitis pocket model in monkeys <xref ref-type="bibr" rid="pntd.0002020-Morrison5">[88]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Lichtenwalner1">[91]</xref>. Interpretation of the role of cHsp60 from these animal models is difficult, since a further study showed that initial immunisation with recombinant antigen in guinea pigs did not produce exacerbated disease after ocular infection with viable organisms but rather may have led to some protective effect <xref ref-type="bibr" rid="pntd.0002020-Rank3">[92]</xref>.</p>
        <p>Human studies on cHsp60 have delivered mixed results on its role in pathogenesis. Antibodies to cHsp60 are associated with trachomatous scarring, pelvic inflammatory disease, and tubal infertility <xref ref-type="bibr" rid="pntd.0002020-Peeling1">[93]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Toye1">[95]</xref>. It is unclear, however, whether these antibodies have a pathogenic role or are simply markers of previous infection. Other studies have suggested that immune responses to cHsp60 may even be protective: examination of PBMC proliferation responses to chlamydial antigens in trachoma endemic populations found that conjunctival scarring was associated with weaker responses to cHsp60, while the resolution of infection was associated with increased responses <xref ref-type="bibr" rid="pntd.0002020-Bailey3">[60]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Holland2">[73]</xref>. Also, as noted above, IFNγ production by PBMC stimulated with cHsp60 is associated with protection against subsequent genital tract re-infection <xref ref-type="bibr" rid="pntd.0002020-Cohen1">[71]</xref>. Overall, there is little evidence from human studies to suggest that scarring trachoma is the result of a DTH reaction to cHsp60.</p>
      </sec>
      <sec id="s8b">
        <title>Differential Activity of CD4+ T-Cell Subsets</title>
        <p>A Th2-dominated response has been linked to the development of scarring complications in some infectious diseases such as schistosomiasis <xref ref-type="bibr" rid="pntd.0002020-Wynn1">[96]</xref>. However, there is little evidence for a similar role in trachoma. Conjunctival gene expression profiling in children with active disease and <italic>Ct</italic> infection found an increase in both Th1 (<italic>IFNγ</italic>) and Th2 (<italic>IL-4</italic>) cytokine expression (Table S3) <xref ref-type="bibr" rid="pntd.0002020-Faal1">[33]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton4">[61]</xref>. Adults with scarring, compared to controls, have reduced lymphoproliferative responses and IFNγ production in response to stimulation with <italic>Ct</italic> EB and some antigens, but an increased number of IL-4–producing cells in response to cHsp60 <xref ref-type="bibr" rid="pntd.0002020-Holland2">[73]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Holland3">[97]</xref>. This seems to support the hypothesis that individuals with scarring may have weaker Th1 cell-mediated responses to <italic>Ct</italic>, leading to prolonged infection and inflammation possibly as a result of Th2 responses with pro-fibrotic effects. However, recent studies comparing the conjunctival transcriptome by microarray, and RT-PCR expression of selected targets, in subjects with scarring trachoma and matched controls found no evidence for Th2 responses and only indirect evidence of increased expression of genes associated with Th1 cells <xref ref-type="bibr" rid="pntd.0002020-Holland4">[98]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Hu2">[100]</xref>. Furthermore, the expression of <italic>IL-13</italic> was lower in individuals with established conjunctival scarring and inflammation, compared to healthy controls. Additionally, Th2 cytokine levels in tear fluid were not increased in scarred individuals (Table S6) <xref ref-type="bibr" rid="pntd.0002020-Skwor1">[101]</xref>.</p>
        <p>The role other types of CD4+ T cells play in trachoma pathogenesis has received little attention. One study showed that the expression of <italic>FOXP3</italic>, used as an indicator of regulatory T cells, was increased in children who had clinical signs of trachoma but in whom infection had resolved <xref ref-type="bibr" rid="pntd.0002020-Faal2">[62]</xref>. However, whether this role is beneficial, by dampening the immune response and subsequent tissue damage once infection has been cleared, or detrimental, by impeding removal of infectious agent, is unknown. The expression of <italic>IL-17A</italic>, suggestive of Th17 cell activity, has been found to be significantly increased in active trachoma (discussed below) <xref ref-type="bibr" rid="pntd.0002020-Natividad1">[50]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Natividad2">[102]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton7">[103]</xref>.</p>
      </sec>
    </sec>
    <sec id="s9">
      <title>The “Cellular Paradigm” and Trachoma</title>
      <p>In the “cellular paradigm,” tissue damage and scarring are thought to be driven by infected epithelial cells, which serve as early innate system responders <xref ref-type="bibr" rid="pntd.0002020-Darville1">[46]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Stephens1">[86]</xref>. Pro-inflammatory chemokines, cytokines, and growth factors produced by <italic>Ct</italic>-infected epithelial cells initiate the recruitment of inflammatory immune cells (neutrophils, macrophages, and NK cells). Infected epithelial cells express multiple factors, which also promote the CMI response and are chemotactic for lymphocytes. The “cellular paradigm” does not differentiate between damage resulting from professional innate immune cells, such as neutrophils and monocytes, and adaptive immune cells <xref ref-type="bibr" rid="pntd.0002020-Darville1">[46]</xref>. However, it does propose that chronic inflammatory responses, tissue damage, and fibrosis in <italic>Ct</italic>-related disease is largely driven from the epithelium rather than by CMI. There is now increasing evidence that innate immune responses are a prominent feature of responses in trachoma and likely interact with the adaptive response.</p>
      <p>Animal studies have shown an influx of neutrophils into genital tract tissue following <italic>Ct</italic> inoculation <xref ref-type="bibr" rid="pntd.0002020-Kelly1">[104]</xref>. Neutrophils were not required to clear infection, however the intensity of the neutrophil infiltrate was related to subsequent fibrotic sequelae <xref ref-type="bibr" rid="pntd.0002020-Frazer1">[105]</xref>. A guinea pig model of trachoma examining neutrophil depletion showed no effect on the burden of infection, however there was less clinical inflammation and fewer mucosal erosions histologically <xref ref-type="bibr" rid="pntd.0002020-Lacy1">[16]</xref>. In this study, adaptive immune responses were also affected with reduced CD4+ and CD8+ cell recruitment and changes in the expression of various cytokines and chemokines such as decreased <italic>CCL5</italic>. This study only evaluated animals for up to 7 days, and once again caution needs to be exercised in extrapolating results of animal models to humans. However, it does provide an insight into the role of innate immunity in trachoma pathogenesis and how this might partly be mediated through its interaction with adaptive responses.</p>
      <p>The production of pro-inflammatory cytokines in response to <italic>Ct</italic> infection is mediated in part through recognition of pathogen-associated molecular patterns (PAMPs) by Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs) <xref ref-type="bibr" rid="pntd.0002020-Roan1">[106]</xref>. While TLR2 knockout (KO) mice were able to eradicate infection in a similar manner to control mice, they had reduced TNFα and CXCL2 <xref ref-type="bibr" rid="pntd.0002020-Darville2">[107]</xref>. Of particular note is the observation that TLR2-KO mice also had a marked reduction in late oviduct pathology. Human genetic studies on TLR polymorphisms have yet to identify significant associations with chlamydial diseases <xref ref-type="bibr" rid="pntd.0002020-Karimi1">[108]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Ouburg1">[110]</xref>.</p>
      <p>In children with active trachoma, IL-1 has been found in the surface epithelial cells of cases, but not controls <xref ref-type="bibr" rid="pntd.0002020-AbuelAsrar1">[48]</xref>. This might promote recruitment of innate immune cells, including neutrophils and macrophages, which are indeed seen in large numbers in the subepithelial substantia propria of children with active trachoma <xref ref-type="bibr" rid="pntd.0002020-Abrahams1">[40]</xref>, <xref ref-type="bibr" rid="pntd.0002020-elAsrar1">[41]</xref>. In vivo confocal microscopy of the conjunctival surface has shown that most of the cellular infiltrate in active and scarring trachoma is concentrated just below the epithelium, supporting the importance of the epithelial cell layer as a source of chemotactic factors <xref ref-type="bibr" rid="pntd.0002020-Hu3">[111]</xref>.</p>
      <p>For both active and scarring trachoma conjunctival transcriptome, studies found prominent innate immune responses <xref ref-type="bibr" rid="pntd.0002020-Natividad1">[50]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton6">[99]</xref>. In children with active disease and/or <italic>Ct</italic> infection, there was marked enrichment of neutrophil and NK-cell-related transcripts <xref ref-type="bibr" rid="pntd.0002020-Natividad1">[50]</xref>. In addition, several PRR and chemokines including the neutrophil chemotactic factor <italic>CXCL5</italic> were increased <xref ref-type="bibr" rid="pntd.0002020-Burton7">[103]</xref>. In adults with scarring and little <italic>Ct</italic> infection, there was also strong evidence for an innate immune response, with some of the most abundant increases in gene expression found for pro-inflammatory mediators such as Psoriasin-1 (<italic>S100A7</italic>), <italic>IL-1B</italic>, and <italic>CXCL5</italic> <xref ref-type="bibr" rid="pntd.0002020-Burton6">[99]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Hu2">[100]</xref>. These factors induce neutrophil chemotaxis and were particularly increased in inflamed cases. The importance of the chemokine response in trachoma is further supported by the finding that genetic variation across the <italic>IL-8</italic> locus, defined by haplotypes of multiple single nucleotide polymorphisms (SNPs), was associated with scarring <xref ref-type="bibr" rid="pntd.0002020-Natividad3">[112]</xref>.</p>
      <p>TNFα, while not specific to innate immune processes, is a key cytokine in acute inflammation and has been associated with scarring trachoma in several studies: a SNP in the <italic>TNFA</italic> promoter region, elevated levels in tear fluid, and increased secretion from peripheral blood mononuclear cells (PBMCs) from scarred subjects stimulated with EBs <xref ref-type="bibr" rid="pntd.0002020-Skwor1">[101]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Conway1">[113]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Atik1">[115]</xref>. Increased transcript levels of <italic>TNFA</italic>, as well as <italic>IL-1B</italic>, have also been associated with active disease/infection <xref ref-type="bibr" rid="pntd.0002020-Faal1">[33]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton4">[61]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Bobo1">[116]</xref>.</p>
      <p>There is increasing evidence that nonchlamydial bacterial infection could play a role in the pathogenesis of trachoma and that this is likely to be through innate mechanisms. While infection with <italic>Ct</italic> is often found in children with active trachoma, it is only rarely identified in adults, as discussed above. Infection with bacteria other than <italic>Ct</italic>, however, is more common in individuals with conjunctival scarring, trichiasis, or its recurrence after surgery, compared to controls, and it is also more common in active disease <xref ref-type="bibr" rid="pntd.0002020-Burton2">[36]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton3">[37]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton8">[117]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Hu4">[119]</xref>. This nonchlamydial bacterial infection is associated with elevated expression of a number of antimicrobial peptides, pro-inflammatory mediators, and modifiers of the extracellular matrix (ECM) including <italic>CXCL5</italic>, <italic>S100A7</italic>, <italic>DEFB4A</italic>, <italic>IL-1B</italic>, and <italic>MMPs 1</italic>, <italic>9</italic>, <italic>10</italic>, and <italic>12</italic> <xref ref-type="bibr" rid="pntd.0002020-Hu2">[100]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton7">[103]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton10">[120]</xref>. It is tempting to postulate that the conjunctiva of individuals who have been repeatedly infected with <italic>Ct</italic> undergoes morphological/immunological changes, rendering it susceptible to nonchlamydial bacterial infection, and that this subsequent infection causes an exaggerated inflammatory response with propagation of the scarring process. However, it is also possible that nonchlamydial bacterial infection may itself promote <italic>Ct</italic> infection or the different types of infection may act synergistically.</p>
    </sec>
    <sec id="s10">
      <title>A Role for IL-17A in Trachoma?</title>
      <p>Neither the “immunological” nor “cellular paradigms” completely accommodate the published data regarding trachoma pathogenesis. Initial studies suggest that IL-17A may be important in trachoma pathogenesis <xref ref-type="bibr" rid="pntd.0002020-Natividad1">[50]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton7">[103]</xref>. IL-17A is the signature cytokine of Th17 cells, a CD4+ T-cell population that act in an antigen-specific manner <xref ref-type="bibr" rid="pntd.0002020-Onishi1">[121]</xref>. However, it is also produced by several other cell types, notably innate immune cells (γδ T cells, NK cells, macrophages, neutrophils), and it can contribute to innate inflammatory responses <xref ref-type="bibr" rid="pntd.0002020-Reynolds1">[122]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Khader1">[123]</xref>. The IL-17A receptor is found on various cell types including dendritic cells, lymphocytes, epithelial cells, and fibroblasts <xref ref-type="bibr" rid="pntd.0002020-Torrado1">[124]</xref>. IL-17A is pro-inflammatory and plays an important role in host immunity to extracellular and some intracellular pathogens <xref ref-type="bibr" rid="pntd.0002020-Kolls1">[125]</xref>. Recently, it has become apparent that IL-17A may contribute to fibrosis through several mechanisms including epithelial-mesenchymal transition (EMT) and increased collagen production in a TGFβ1-dependant manner <xref ref-type="bibr" rid="pntd.0002020-Mi1">[126]</xref>. Infection of mice with <italic>Mycobacterium tuberculosis</italic> followed by repeated BCG injections led to an IL-17A–dominated response, which was refractory to regulation by IFNγ <xref ref-type="bibr" rid="pntd.0002020-Cruz1">[127]</xref>. This caused extensive lung tissue damage by neutrophils that could be reduced by anti-IL17A antibody. These observations from TB may have parallels with trachoma, with IL-17A playing a major part in immunopathology, and could have implications for vaccine strategies.</p>
    </sec>
    <sec id="s11">
      <title>Tissue Damage and Fibrogenesis in Trachoma</title>
      <p>Scarring develops when normal tissue architecture is disrupted and replaced by excessive connective tissue through the abnormal accumulation of ECM components. Tissue damage can be mediated through a variety of cell types and mechanisms. Neutrophil infiltration appears important in trachoma: they have been identified in conjunctival biopsies of trachomatous tissue, they produce toxic reactive oxygen and nitrogen species that damage host tissue in animal models of genital tract infection, and they can also produce MMPs <xref ref-type="bibr" rid="pntd.0002020-AbuelAsrar1">[48]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Ramsey5">[128]</xref>. Macrophages are also found in trachomatous tissue and may be important effector cells for tissue damage in chlamydial infection <xref ref-type="bibr" rid="pntd.0002020-AbuelAsrar1">[48]</xref>.</p>
      <p>The matrix metalloproteinases are a group of more than 25 endopeptidases with multiple, complex functions. While MMPs are required for normal tissue homeostasis, there is also evidence that they play a role in the pathogenesis of a range of inflammatory-fibrotic diseases <xref ref-type="bibr" rid="pntd.0002020-Hu5">[129]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Wang2">[131]</xref>. An important step is the disruption of the basement membrane, aiding the recruitment of inflammatory cells <xref ref-type="bibr" rid="pntd.0002020-Wynn2">[132]</xref>. MMPs also have wide-ranging effects on inflammatory and immune processes such as modulating chemokine activity and activation of TGFβ, IL-1β, and TNFα. <xref ref-type="bibr" rid="pntd.0002020-Parks1">[133]</xref>. They are known to be important in a number of ocular surface diseases, and inhibition of MMP activity has been shown to reduce conjunctival scarring after glaucoma surgery <xref ref-type="bibr" rid="pntd.0002020-Wong1">[134]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Wong2">[135]</xref>.</p>
      <p>MMP9 in particular has been studied extensively in trachoma. It is part of the neutrophil lysosome and mediates epithelial dissolution associated with infection through degradation of type IV collagen <xref ref-type="bibr" rid="pntd.0002020-Ramsey5">[128]</xref>. Mouse models of genital tract infection have shown a reduced rate of scarring sequelae in <italic>MMP9</italic> KO animals and that infection is associated with increased MMP9 in genital tract tissue (determined by zymography and gene expression) <xref ref-type="bibr" rid="pntd.0002020-Ramsey1">[15]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Imtiaz1">[136]</xref>. Children with active trachoma have increased amounts of MMP9 (determined by immunohistochemistry, zymography, and gene expression analysis) <xref ref-type="bibr" rid="pntd.0002020-Burton4">[61]</xref>, <xref ref-type="bibr" rid="pntd.0002020-ElAsrar1">[137]</xref>. Scarring trachoma in adults is associated with increased expression of <italic>MMP9</italic> and a coding SNP that is adjacent to the active binding site of the MMP9 enzyme <xref ref-type="bibr" rid="pntd.0002020-Burton4">[61]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Hu2">[100]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Natividad5">[138]</xref>. Scarring trachoma is also associated with differential expression of <italic>MMPs</italic> 7, 9, 10, and 12 and tissue inhibitor of MMP (TIMP)-1, and recurrence of trichiasis after surgery is associated with an altered <italic>MMP1/TIMP1</italic> transcript ratio <xref ref-type="bibr" rid="pntd.0002020-Holland4">[98]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Hu2">[100]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton10">[120]</xref>.</p>
      <p>The production of scar tissue has not been extensively studied in trachoma. However, it probably originates from activated fibroblasts that are stimulated to produce collagen by various pro-fibrogenic mediators (TGF-β, PDGF, CTGF, and bFGF) <xref ref-type="bibr" rid="pntd.0002020-AbuelAsrar1">[48]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton7">[103]</xref>, <xref ref-type="bibr" rid="pntd.0002020-AbuElAsrar1">[139]</xref>. Chemokines have also been shown to act as fibrogenic mediators, in particular the CC- and CXC-chemokine families, and various members of these families have been associated with scarring including the pro-fibrogenic CCL18 <xref ref-type="bibr" rid="pntd.0002020-Wynn1">[96]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Burton6">[99]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Skwor1">[101]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Burton7">[103]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Wynn2">[132]</xref>.</p>
    </sec>
    <sec id="s12">
      <title>Programmatic Implications</title>
      <p>Trachoma is still endemic in over 50 countries and current trachoma control strategies face major obstacles. With regards to mass antibiotic distribution, the coverage levels in practice are often disappointing; there are concerns that mass distribution of azithromycin may lead to an increase in antibiotic resistance, and the “arrested immunity hypothesis,” put forward in the context of genital tract infection, suggests that shortening the duration of chlamydial infection with treatment results in population-wide reductions in protective immunity <xref ref-type="bibr" rid="pntd.0002020-Thylefors1">[140]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Brunham2">[142]</xref>. As well as being potentially the most effective way of reducing blindness from trachoma, a chlamydial vaccine could be very cost effective and have major benefits for genital tract disease caused by <italic>Ct</italic> <xref ref-type="bibr" rid="pntd.0002020-Woodall1">[143]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Frick1">[144]</xref>.</p>
      <p>The human trachoma vaccine studies in the 1960s using inactivated whole EB tended to show only partial, short-term, serovar-specific protection, which was little better than natural immunity and may have resulted in earlier disease onset in some vaccinated individuals <xref ref-type="bibr" rid="pntd.0002020-Nichols1">[67]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Sowa1">[68]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Woolridge1">[83]</xref>, <xref ref-type="bibr" rid="pntd.0002020-Grayston2">[145]</xref>–<xref ref-type="bibr" rid="pntd.0002020-Clements1">[148]</xref>. Understanding the immunobiology of trachoma, including both how infection is successfully cleared and its pathogenesis, is important in the rational design of an effective vaccine that avoids immunopathology. A recent study employed a plasmid-deficient strain of <italic>Ct</italic> to immunise cynomolgus macaque monkeys <xref ref-type="bibr" rid="pntd.0002020-Kari1">[149]</xref>. Attenuated organisms were inoculated directly onto the conjunctival surface and caused minimal/absent ocular inflammation, despite repeated innoculation. On rechallenge with plasmid-bearing organisms, previously infected animals shed markedly less infectious organisms than controls, and three out of six animals showed minimal inflammatory changes compared to marked inflammation in all six control animals. These encouraging results, as well as implicating the <italic>Ct</italic> plasmid as an important virulence factor, support further work into vaccine development. While plasmid-deficient strains of <italic>Ct</italic> are naturally isolated from populations at risk of trachoma, the manipulation of virulence factors and the development of vaccine candidates may be helped by recent advances in <italic>Ct</italic> genetic transformation <xref ref-type="bibr" rid="pntd.0002020-Wang3">[150]</xref>.</p>
    </sec>
    <sec id="s13">
      <title>Conclusion</title>
      <p>The immunology and pathogenesis of trachoma is a challenging but fascinating area of study. Despite considerable efforts, the mechanisms of protective immunity in trachoma remain elusive, although data from animal models suggest these involve IFNγ-dependent CMI responses. Recent data point to the importance of the human innate immune response, epithelial cell responses, EMT, and possible IL-17A involvement in both active disease and the pathogenesis of scarring. The MMPs are important effector enzymes in this tissue damage. There is still a pressing need for further research to better understand this ancient disease. The development of a vaccine would help to overcome the many obstacles that lie in the way of eliminating blinding trachoma.</p>
      <boxed-text id="pntd-0002020-box001" position="float">
        <sec id="s13a1">
          <title>Key Learning Points</title>
          <list list-type="bullet">
            <list-item>
              <p>The immune response to <italic>Ct</italic> provides only partial protection against re-infection and is important in causing tissue scarring and blindness.</p>
            </list-item>
            <list-item>
              <p>Recent evidence has supported the “cellular paradigm” of disease pathogenesis, which states that infected epithelial cell responses drive pathology through the release of various mediators.</p>
            </list-item>
            <list-item>
              <p>A trachoma vaccine would offer significant advantages to trachoma control, but vaccine development is impeded by a limited understanding of disease mechanisms.</p>
            </list-item>
          </list>
        </sec>
      </boxed-text>
      <boxed-text id="pntd-0002020-box002" position="float">
        <sec id="s13b1">
          <title>Key Papers in the Field</title>
          <list list-type="bullet">
            <list-item>
              <p>Stephens RS (2003) The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 11: 44–51.</p>
            </list-item>
            <list-item>
              <p>Darville T, Hiltke TJ Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 201 Suppl 2: S114–S125.</p>
            </list-item>
            <list-item>
              <p>Burton MJ, Rajak SN, Bauer J, Weiss HA, Tolbert SB, et al. (2011) Conjunctival transcriptome in scarring trachoma. Infect Immun 79: 499–511.</p>
            </list-item>
            <list-item>
              <p>Kari L, Whitmire WM, Olivares-Zavaleta N, Goheen MM, Taylor LD, et al. (2011) A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J Exp Med 208: 2217–2223.</p>
            </list-item>
          </list>
        </sec>
      </boxed-text>
    </sec>
    <sec id="s14">
      <title>Supporting Information</title>
      <supplementary-material id="pntd.0002020.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pntd.0002020.s001" position="float" xlink:type="simple">
        <label>Supporting Information S1</label>
        <caption>
          <p>Table S1: Human trachoma genetic studies; Table S2: Histology and immunohistochemistry studies using human tarsal conjunctival biopsies; Table S3: Quantitative gene expression and microarray studies from human tarsal conjunctival swab samples; Table S4: Lymphoproliferative and cytokine studies using human PBMCs; Table S5: Antibody/B-cell responses from human serum, conjunctival, and tear samples; Table S6: Miscellaneous human trachoma studies.</p>
          <p>(DOCX)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pntd.0002020-Resnikoff1">
        <label>1</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Resnikoff</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pascolini</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Etya'ale</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kocur</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Pararajasegaram</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Global data on visual impairment in the year 2002</article-title>. <source>Bull World Health Organ</source> <volume>82</volume>: <fpage>844</fpage>–<lpage>851</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Mariotti1">
        <label>2</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mariotti</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Pascolini</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rose-Nussbaumer</surname><given-names>J</given-names></name> (<year>2009</year>) <article-title>Trachoma: global magnitude of a preventable cause of blindness</article-title>. <source>Br J Ophthalmol</source> <volume>93</volume>: <fpage>563</fpage>–<lpage>568</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-World1">
        <label>3</label>
        <mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2002) Global prevalence and incidence of selectted curable sexually transmitted infections overview and estimates. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/hiv/pub/sti/en/who_hiv_aids_2001.02.pdf" xlink:type="simple">http://www.who.int/hiv/pub/sti/en/who_hiv_aids_2001.02.pdf</ext-link>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Caldwell1">
        <label>4</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Caldwell</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Crane</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>RB</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates</article-title>. <source>J Clin Invest</source> <volume>111</volume>: <fpage>1757</fpage>–<lpage>1769</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-WHO1">
        <label>5</label>
        <mixed-citation publication-type="other" xlink:type="simple">WHO (1998) Global elimination of blinding trachoma. World Health Assembly Resolutin WHA 51.11. Geneva, Switzerland: WHO.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Kuper1">
        <label>6</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuper</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Solomon</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Buchan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zondervan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>A critical review of the SAFE strategy for the prevention of blinding trachoma</article-title>. <source>Lancet Infect Dis</source> <volume>3</volume>: <fpage>372</fpage>–<lpage>381</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Emerson1">
        <label>7</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Emerson</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Burton</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Solomon</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>D</given-names></name> (<year>2006</year>) <article-title>The SAFE strategy for trachoma control: using operational research for policy, planning and implementation</article-title>. <source>Bull World Health Organ</source> <volume>84</volume>: <fpage>613</fpage>–<lpage>619</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Taylor1">
        <label>8</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taylor</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Prendergast</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Dawson</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Schachter</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Silverstein</surname><given-names>AM</given-names></name> (<year>1981</year>) <article-title>An animal model for cicatrizing trachoma</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>21</volume>: <fpage>422</fpage>–<lpage>433</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Taylor2">
        <label>9</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taylor</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Prendergast</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Schachter</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dawson</surname><given-names>CR</given-names></name>, <etal>et al</etal>. (<year>1982</year>) <article-title>An animal model of trachoma II. The importance of repeated reinfection</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>23</volume>: <fpage>507</fpage>–<lpage>515</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Grayston1">
        <label>10</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grayston</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>CC</given-names></name> (<year>1985</year>) <article-title>Importance of reinfection in the pathogenesis of trachoma</article-title>. <source>Rev Infect Dis</source> <volume>7</volume>: <fpage>717</fpage>–<lpage>725</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Taylor3">
        <label>11</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taylor</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Schachter</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Caldwell</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Prendergast</surname><given-names>RA</given-names></name> (<year>1987</year>) <article-title>Pathogenesis of trachoma: the stimulus for inflammation</article-title>. <source>J Immunol</source> <volume>138</volume>: <fpage>3023</fpage>–<lpage>3027</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Taylor4">
        <label>12</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taylor</surname><given-names>HR</given-names></name> (<year>1985</year>) <article-title>Ocular models of chlamydial infection</article-title>. <source>Rev Infect Dis</source> <volume>7</volume>: <fpage>737</fpage>–<lpage>740</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-TaylorRobinson1">
        <label>13</label>
        <mixed-citation publication-type="other" xlink:type="simple">Taylor-Robinson D (1986) The role of animal models in chlamydial research. In: Oriel D, Ridgway G, Schachter J, Taylor-Robinson D, Ward M, editors. Surrey. Cambridge University Press. pp. 355–366.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Shah1">
        <label>14</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shah</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Schripsema</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Imtiaz</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Sigar</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Kasimos</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum</article-title>. <source>Sex Transm Dis</source> <volume>32</volume>: <fpage>49</fpage>–<lpage>56</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Ramsey1">
        <label>15</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramsey</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Sigar</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Schripsema</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Shaba</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Cohoon</surname><given-names>KP</given-names></name> (<year>2005</year>) <article-title>Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice</article-title>. <source>Infect Immun</source> <volume>73</volume>: <fpage>6962</fpage>–<lpage>6973</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Lacy1">
        <label>16</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lacy</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Bowlin</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Hennings</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Scurlock</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Nagarajan</surname><given-names>UM</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Essential role for neutrophils in pathogenesis and adaptive immunity in Chlamydia caviae ocular infections</article-title>. <source>Infect Immun</source> <volume>79</volume>: <fpage>1889</fpage>–<lpage>1897</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Treharne1">
        <label>17</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Treharne</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Shallal</surname><given-names>A</given-names></name> (<year>1991</year>) <article-title>The antigenic specificity of the humoral immune response to primary and repeated ocular infections of the guinea pig with the GPIC agent (Chlamydia psittaci)</article-title>. <source>Eye</source> <volume>5</volume> (<issue>Pt 3</issue>)  <fpage>299</fpage>–<lpage>304</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Mestas1">
        <label>18</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mestas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hughes</surname><given-names>CC</given-names></name> (<year>2004</year>) <article-title>Of mice and not men: differences between mouse and human immunology</article-title>. <source>J Immunol</source> <volume>172</volume>: <fpage>2731</fpage>–<lpage>2738</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wright1">
        <label>19</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wright</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>HR</given-names></name> (<year>2005</year>) <article-title>Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us?</article-title> <source>Lancet Infect Dis</source> <volume>5</volume>: <fpage>313</fpage>–<lpage>320</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Bailey1">
        <label>20</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Hampton</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Whittle</surname><given-names>HC</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities</article-title>. <source>J Infect Dis</source> <volume>170</volume>: <fpage>709</fpage>–<lpage>712</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-West1">
        <label>21</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>West</surname><given-names>SK</given-names></name> (<year>2004</year>) <article-title>Trachoma: new assault on an ancient disease</article-title>. <source>Prog Retin Eye Res</source> <volume>23</volume>: <fpage>381</fpage>–<lpage>401</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Emerson2">
        <label>22</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Emerson</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Cairncross</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>DC</given-names></name> (<year>2000</year>) <article-title>Review of the evidence base for the ‘F’ and ‘E’ components of the SAFE strategy for trachoma control</article-title>. <source>Trop Med Int Health</source> <volume>5</volume>: <fpage>515</fpage>–<lpage>527</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Hu1">
        <label>23</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>VH</given-names></name>, <name name-style="western"><surname>Harding-Esch</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Kadimpeul</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Epidemiology and control of trachoma: systematic review</article-title>. <source>Trop Med Int Health</source> <volume>15</volume>: <fpage>673</fpage>–<lpage>691</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-West2">
        <label>24</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>West</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mkocha</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>MC</given-names></name> (<year>2001</year>) <article-title>Progression of active trachoma to scarring in a cohort of Tanzanian children</article-title>. <source>Ophthalmic Epidemiol</source> <volume>8</volume>: <fpage>137</fpage>–<lpage>144</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Dawson1">
        <label>25</label>
        <mixed-citation publication-type="other" xlink:type="simple">Dawson CR MR, Daghfous R, Juster R, Schachter J (1990) What clinical signs are critical in evaluating the impact of intervention in trachoma? Chlamydia Infections. Proceedings of the Seventh International Symposium on Human Chlamydial Infections. London: Cambridge University Press. pp. 271–275.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Munoz1">
        <label>26</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Munoz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bobo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Mkocha</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>YH</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Incidence of trichiasis in a cohort of women with and without scarring</article-title>. <source>Int J Epidemiol</source> <volume>28</volume>: <fpage>1167</fpage>–<lpage>1171</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton1">
        <label>27</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bowman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Faal</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Aryee</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Ikumapayi</surname><given-names>UN</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>The long-term natural history of trachomatous trichiasis in the Gambia</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>47</volume>: <fpage>847</fpage>–<lpage>852</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wolle1">
        <label>28</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolle</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Mkocha</surname><given-names>H</given-names></name>, <name name-style="western"><surname>West</surname><given-names>SK</given-names></name> (<year>2009</year>) <article-title>Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania</article-title>. <source>Ophthalmology</source> <volume>116</volume>: <fpage>243</fpage>–<lpage>247</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Congdon1">
        <label>29</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Congdon</surname><given-names>N</given-names></name>, <name name-style="western"><surname>West</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vitale</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Katala</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mmbaga</surname><given-names>BB</given-names></name> (<year>1993</year>) <article-title>Exposure to children and risk of active trachoma in Tanzanian women</article-title>. <source>Am J Epidemiol</source> <volume>137</volume>: <fpage>366</fpage>–<lpage>372</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-King1">
        <label>30</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>King</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Ngondi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gatpan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lopidia</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Becknell</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>The burden of trachoma in ayod county of southern Sudan</article-title>. <source>PLoS Negl Trop Dis</source> <volume>2</volume>: <fpage>e299</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000299" xlink:type="simple">10.1371/journal.pntd.0000299</ext-link></comment></mixed-citation>
      </ref>
      <ref id="pntd.0002020-Ngondi1">
        <label>31</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ngondi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ole-Sempele</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Onsarigo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Matende</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Baba</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Blinding trachoma in postconflict southern Sudan</article-title>. <source>PLoS Med</source> <volume>3</volume>: <fpage>e478</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0030478" xlink:type="simple">10.1371/journal.pmed.0030478</ext-link></comment></mixed-citation>
      </ref>
      <ref id="pntd.0002020-TaylorHR1">
        <label>32</label>
        <mixed-citation publication-type="other" xlink:type="simple">TaylorHR (2008) Trachoma: a blinding scourge from the Bronze Age to the twenty-first century. Melbourne: Haddington Press.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Faal1">
        <label>33</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Faal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Sarr</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Joof</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>DC</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Temporal cytokine gene expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection</article-title>. <source>Clin Exp Immunol</source> <volume>142</volume>: <fpage>347</fpage>–<lpage>353</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wyrick1">
        <label>34</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wyrick</surname><given-names>PB</given-names></name> (<year>2010</year>) <article-title>Chlamydia trachomatis persistence in vitro: an overview</article-title>. <source>J Infect Dis</source> <volume>201</volume><supplement>Suppl 2</supplement>: <fpage>S88</fpage>–<lpage>S95</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Smith1">
        <label>35</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Bobo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Mkocha</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women</article-title>. <source>Ophthalmic Epidemiol</source> <volume>8</volume>: <fpage>127</fpage>–<lpage>135</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton2">
        <label>36</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Kinteh</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Jallow</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Sillah</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bah</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia</article-title>. <source>Br J Ophthalmol</source> <volume>89</volume>: <fpage>1282</fpage>–<lpage>1288</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton3">
        <label>37</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Adegbola</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Kinteh</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ikumapayi</surname><given-names>UN</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Bacterial infection and trachoma in the gambia: a case control study</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>48</volume>: <fpage>4440</fpage>–<lpage>4444</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-West3">
        <label>38</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>West</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Mkocha</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>46</volume>: <fpage>447</fpage>–<lpage>453</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Bailey2">
        <label>39</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bailey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Duong</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Carpenter</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Whittle</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>D</given-names></name> (<year>1999</year>) <article-title>The duration of human ocular Chlamydia trachomatis infection is age dependent</article-title>. <source>Epidemiol Infect</source> <volume>123</volume>: <fpage>479</fpage>–<lpage>486</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Abrahams1">
        <label>40</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abrahams</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ballard</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Sutter</surname><given-names>EE</given-names></name> (<year>1979</year>) <article-title>The pathology of trachoma in a black South African population. Light microscopical, histochemical and electron microscopical findings</article-title>. <source>S Afr Med J</source> <volume>55</volume>: <fpage>1115</fpage>–<lpage>1118</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-elAsrar1">
        <label>41</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>el-Asrar</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Van den Oord</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Geboes</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Missotten</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Emarah</surname><given-names>MH</given-names></name>, <etal>et al</etal>. (<year>1989</year>) <article-title>Immunopathology of trachomatous conjunctivitis</article-title>. <source>Br J Ophthalmol</source> <volume>73</volume>: <fpage>276</fpage>–<lpage>282</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Guzey1">
        <label>42</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guzey</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ozardali</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Basar</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Aslan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Satici</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>A survey of trachoma: the histopathology and the mechanism of progressive cicatrization of eyelid tissues</article-title>. <source>Ophthalmologica</source> <volume>214</volume>: <fpage>277</fpage>–<lpage>284</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-alRajhi1">
        <label>43</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>al-Rajhi</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Hidayat</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nasr</surname><given-names>A</given-names></name>, <name name-style="western"><surname>al-Faran</surname><given-names>M</given-names></name> (<year>1993</year>) <article-title>The histopathology and the mechanism of entropion in patients with trachoma</article-title>. <source>Ophthalmology</source> <volume>100</volume>: <fpage>1293</fpage>–<lpage>1296</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Reacher1">
        <label>44</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reacher</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Pe'er</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rapoza</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Whittum-Hudson</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>HR</given-names></name> (<year>1991</year>) <article-title>T cells and trachoma. Their role in cicatricial disease</article-title>. <source>Ophthalmology</source> <volume>98</volume>: <fpage>334</fpage>–<lpage>341</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Rasmussen1">
        <label>45</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rasmussen</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Eckmann</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Quayle</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>YX</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis</article-title>. <source>J Clin Invest</source> <volume>99</volume>: <fpage>77</fpage>–<lpage>87</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Darville1">
        <label>46</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><article-title>Darville T, Hiltke TJ (201) Pathogenesis of genital tract disease due to Chlamydia trachomatis</article-title>. <source>J Infect Dis</source> <volume>201</volume><supplement>Suppl 2</supplement>: <fpage>S114</fpage>–<lpage>S125</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Johnson1">
        <label>47</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnson</surname><given-names>RM</given-names></name> (<year>2004</year>) <article-title>Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion</article-title>. <source>Infect Immun</source> <volume>72</volume>: <fpage>3951</fpage>–<lpage>3960</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-AbuelAsrar1">
        <label>48</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abu el-Asrar</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Geboes</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tabbara</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>al-Kharashi</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Missotten</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Immunopathogenesis of conjunctival scarring in trachoma</article-title>. <source>Eye</source> <volume>12</volume> (<issue>Pt 3a</issue>)  <fpage>453</fpage>–<lpage>460</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Mabey1">
        <label>49</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mabey</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Dunn</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>JH</given-names></name>, <etal>et al</etal>. (<year>1991</year>) <article-title>Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease</article-title>. <source>J Clin Pathol</source> <volume>44</volume>: <fpage>285</fpage>–<lpage>289</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Natividad1">
        <label>50</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Natividad</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Freeman</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Jeffries</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>DC</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection</article-title>. <source>Infect Immun</source> <volume>78</volume>: <fpage>4895</fpage>–<lpage>4911</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Gall1">
        <label>51</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gall</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Horowitz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Joof</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Natividad</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tetteh</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis</article-title>. <source>Front Microbiol</source> <volume>2</volume>: <fpage>10</fpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Rank1">
        <label>52</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rank</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Soderberg</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Barron</surname><given-names>AL</given-names></name> (<year>1985</year>) <article-title>Chronic chlamydial genital infection in congenitally athymic nude mice</article-title>. <source>Infect Immun</source> <volume>48</volume>: <fpage>847</fpage>–<lpage>849</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Ramsey2">
        <label>53</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramsey</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Rank</surname><given-names>RG</given-names></name> (<year>1991</year>) <article-title>Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines</article-title>. <source>Infect Immun</source> <volume>59</volume>: <fpage>925</fpage>–<lpage>931</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Morrison1">
        <label>54</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morrison</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Farris</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Sturdevant</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Whitmire</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>RP</given-names></name> (<year>2011</year>) <article-title>Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity</article-title>. <source>J Infect Dis</source> <volume>203</volume>: <fpage>1120</fpage>–<lpage>1128</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Brunham1">
        <label>55</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brunham</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Rey-Ladino</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine</article-title>. <source>Nat Rev Immunol</source> <volume>5</volume>: <fpage>149</fpage>–<lpage>161</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Thomas1">
        <label>56</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomas</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Garrity</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Brandt</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Schobert</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>GS</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth</article-title>. <source>J Immunol</source> <volume>150</volume>: <fpage>5529</fpage>–<lpage>5534</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Rapoza1">
        <label>57</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rapoza</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Tahija</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Carlin</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Padilla</surname><given-names>ML</given-names></name>, <etal>et al</etal>. (<year>1991</year>) <article-title>Effect of interferon on a primary conjunctival epithelial cell model of trachoma</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>32</volume>: <fpage>2919</fpage>–<lpage>2923</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Ramsey3">
        <label>58</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramsey</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Miranpuri</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Sigar</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Ouellette</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Byrne</surname><given-names>GI</given-names></name> (<year>2001</year>) <article-title>Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome</article-title>. <source>Infect Immun</source> <volume>69</volume>: <fpage>5131</fpage>–<lpage>5137</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Igietseme1">
        <label>59</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Igietseme</surname><given-names>JU</given-names></name>, <name name-style="western"><surname>Ananaba</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Candal</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Lyn</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>CM</given-names></name> (<year>1998</year>) <article-title>Immune control of Chlamydial growth in the human epithelial cell line RT4 involves multiple mechanisms that include nitric oxide induction, tryptophan catabolism and iron deprivation</article-title>. <source>Microbiol Immunol</source> <volume>42</volume>: <fpage>617</fpage>–<lpage>625</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Bailey3">
        <label>60</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Whittle</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>DC</given-names></name> (<year>1995</year>) <article-title>Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls</article-title>. <source>Infect Immun</source> <volume>63</volume>: <fpage>389</fpage>–<lpage>392</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton4">
        <label>61</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Jeffries</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name> (<year>2004</year>) <article-title>Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic</article-title>. <source>Infect Immun</source> <volume>72</volume>: <fpage>7352</fpage>–<lpage>7356</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Faal2">
        <label>62</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Faal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Jeffries</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Joof</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sarr</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?</article-title> <source>PLoS Med</source> <volume>3</volume>: <fpage>e266</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0030266" xlink:type="simple">10.1371/journal.pmed.0030266</ext-link></comment></mixed-citation>
      </ref>
      <ref id="pntd.0002020-Holland1">
        <label>63</label>
        <mixed-citation publication-type="other" xlink:type="simple">Holland MJ, Faal N, Jeffries D, Joof H, Sarr I, <etal>et al</etal>.. (2010) Human ocular Chlamydia trachomatis disease, infection and immune responses examine using quantitative conjunctival gene expression with intensive longitudianl follow-up and gene co-expression analysis. Salzburg. pp. 145–148.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Jawetz1">
        <label>64</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jawetz</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hanna</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Thygeson</surname><given-names>P</given-names></name> (<year>1965</year>) <article-title>Experimental inclusion conjunctivitis in man: measurements of infectivity and resistance</article-title>. <source>JAMA</source> <volume>194</volume>: <fpage>620</fpage>–<lpage>632</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Dawson2">
        <label>65</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dawson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jawetz</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hanna</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>TR</given-names></name>, <etal>et al</etal>. (<year>1966</year>) <article-title>Experimental inclusion conjunctivitis in man. II. Partial resistance to reinfection</article-title>. <source>Am J Epidemiol</source> <volume>84</volume>: <fpage>411</fpage>–<lpage>425</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Tarizzo1">
        <label>66</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tarizzo</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Nataf</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nabli</surname><given-names>B</given-names></name> (<year>1967</year>) <article-title>Experimental inoculation of thirteen volunteers with agent isolated from inclusion conjunctivitis</article-title>. <source>Am J Ophthalmol</source> <volume>63</volume> <supplement>Suppl</supplement> <fpage>1120</fpage>–<lpage>1128</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Nichols1">
        <label>67</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nichols</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>SD</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Haddad</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Bobb</surname><given-names>AA</given-names></name> (<year>1969</year>) <article-title>Studies on trachoma. VI. Microbiological observations in a field trial in Saudi Arabia of bivalent rachoma vaccine at three dosage levels</article-title>. <source>Am J Trop Med Hyg</source> <volume>18</volume>: <fpage>723</fpage>–<lpage>730</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Sowa1">
        <label>68</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sowa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sowa</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Collier</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Blyth</surname><given-names>WA</given-names></name> (<year>1969</year>) <article-title>Trachoma vaccine field trials in The Gambia</article-title>. <source>J Hyg (Lond)</source> <volume>67</volume>: <fpage>699</fpage>–<lpage>717</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Grassly1">
        <label>69</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grassly</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Ferris</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name> (<year>2008</year>) <article-title>The natural history of trachoma infection and disease in a gambian cohort with frequent follow-up</article-title>. <source>PLoS Negl Trop Dis</source> <volume>2</volume>: <fpage>e341</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000341" xlink:type="simple"> 10.1371/journal.pntd.0000341</ext-link></comment></mixed-citation>
      </ref>
      <ref id="pntd.0002020-Rank2">
        <label>70</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rank</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Whittum-Hudson</surname><given-names>JA</given-names></name> (<year>2010</year>) <article-title>Protective immunity to chlamydial genital infection: evidence from animal studies</article-title>. <source>J Infect Dis</source> <volume>201</volume><supplement>Suppl 2</supplement>: <fpage>S168</fpage>–<lpage>S177</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Cohen1">
        <label>71</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohen</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Koochesfahani</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Meier</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Karunakaran</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma</article-title>. <source>J Infect Dis</source> <volume>192</volume>: <fpage>591</fpage>–<lpage>599</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Bailey4">
        <label>72</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Kajbaf</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Whittle</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>DC</given-names></name> (<year>1993</year>) <article-title>The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective</article-title>. <source>Epidemiol Infect</source> <volume>111</volume>: <fpage>315</fpage>–<lpage>324</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Holland2">
        <label>73</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Whittle</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Mabey</surname><given-names>DC</given-names></name> (<year>1993</year>) <article-title>Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens</article-title>. <source>J Infect Dis</source> <volume>168</volume>: <fpage>1528</fpage>–<lpage>1531</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Lu1">
        <label>74</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Genome-wide identification of Chlamydia trachomatis antigens associated with trachomatous trichiasis</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>53</volume>: <fpage>2551</fpage>–<lpage>2559</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Ramsey4">
        <label>75</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramsey</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Soderberg</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Rank</surname><given-names>RG</given-names></name> (<year>1988</year>) <article-title>Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection</article-title>. <source>Infect Immun</source> <volume>56</volume>: <fpage>1320</fpage>–<lpage>1325</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Su1">
        <label>76</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Su</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Feilzer</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Caldwell</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>RP</given-names></name> (<year>1997</year>) <article-title>Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice</article-title>. <source>Infect Immun</source> <volume>65</volume>: <fpage>1993</fpage>–<lpage>1999</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Morrison2">
        <label>77</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morrison</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Caldwell</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>RP</given-names></name> (<year>2000</year>) <article-title>Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells</article-title>. <source>Infect Immun</source> <volume>68</volume>: <fpage>6979</fpage>–<lpage>6987</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Morrison3">
        <label>78</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morrison</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>RP</given-names></name> (<year>2001</year>) <article-title>Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells</article-title>. <source>Infect Immun</source> <volume>69</volume>: <fpage>2643</fpage>–<lpage>2649</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Morrison4">
        <label>79</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morrison</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>RP</given-names></name> (<year>2005</year>) <article-title>A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection</article-title>. <source>J Immunol</source> <volume>175</volume>: <fpage>7536</fpage>–<lpage>7542</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Crane1">
        <label>80</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crane</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Carlson</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Bavoil</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hsia</surname><given-names>RC</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>103</volume>: <fpage>1894</fpage>–<lpage>1899</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Silverstein1">
        <label>81</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Silverstein</surname><given-names>AM</given-names></name> (<year>1974</year>) <article-title>The immunologic modulation of infectious disease pathogenesis. Friedenwald Lecture, 1973</article-title>. <source>Invest Ophthalmol</source> <volume>13</volume>: <fpage>560</fpage>–<lpage>574</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton5">
        <label>82</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Faal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Aryee</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Alexander</surname><given-names>ND</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>44</volume>: <fpage>4215</fpage>–<lpage>4222</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Woolridge1">
        <label>83</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woolridge</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Grayston</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>IH</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>CY</given-names></name>, <etal>et al</etal>. (<year>1967</year>) <article-title>Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children</article-title>. <source>Am J Ophthalmol</source> <volume>63</volume> <supplement>Suppl</supplement>  <fpage>1645</fpage>–<lpage>1650</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Taylor5">
        <label>84</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taylor</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Schachter</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Prendergast</surname><given-names>RA</given-names></name> (<year>1983</year>) <article-title>An animal model of trachoma: IV. The failure of local immunosuppression to reveal inapparent infection</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>24</volume>: <fpage>647</fpage>–<lpage>650</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wang1">
        <label>85</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Grayston</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Alexander</surname><given-names>ER</given-names></name> (<year>1967</year>) <article-title>Trachoma vaccine studies in monkeys</article-title>. <source>Am J Ophthalmol</source> <volume>63</volume> <supplement>Suppl</supplement> <fpage>1615</fpage>–<lpage>1630</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Stephens1">
        <label>86</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stephens</surname><given-names>RS</given-names></name> (<year>2003</year>) <article-title>The cellular paradigm of chlamydial pathogenesis</article-title>. <source>Trends Microbiol</source> <volume>11</volume>: <fpage>44</fpage>–<lpage>51</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Watkins1">
        <label>87</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Watkins</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Hadlow</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Moos</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Caldwell</surname><given-names>HD</given-names></name> (<year>1986</year>) <article-title>Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>83</volume>: <fpage>7480</fpage>–<lpage>7484</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Morrison5">
        <label>88</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morrison</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Belland</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Lyng</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Caldwell</surname><given-names>HD</given-names></name> (<year>1989</year>) <article-title>Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein</article-title>. <source>J Exp Med</source> <volume>170</volume>: <fpage>1271</fpage>–<lpage>1283</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Morrison6">
        <label>89</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morrison</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Lyng</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Caldwell</surname><given-names>HD</given-names></name> (<year>1989</year>) <article-title>Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein</article-title>. <source>J Exp Med</source> <volume>169</volume>: <fpage>663</fpage>–<lpage>675</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Patton1">
        <label>90</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Patton</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Sweeney</surname><given-names>YT</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>CC</given-names></name> (<year>1994</year>) <article-title>Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in monkeys: a pathogenic mechanism of tubal damage</article-title>. <source>J Infect Dis</source> <volume>169</volume>: <fpage>680</fpage>–<lpage>683</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Lichtenwalner1">
        <label>91</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lichtenwalner</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Patton</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Van Voorhis</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Sweeney</surname><given-names>YT</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>CC</given-names></name> (<year>2004</year>) <article-title>Heat shock protein 60 is the major antigen which stimulates delayed-type hypersensitivity reaction in the macaque model of Chlamydia trachomatis salpingitis</article-title>. <source>Infect Immun</source> <volume>72</volume>: <fpage>1159</fpage>–<lpage>1161</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Rank3">
        <label>92</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rank</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Dascher</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bowlin</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Bavoil</surname><given-names>PM</given-names></name> (<year>1995</year>) <article-title>Systemic immunization with Hsp60 alters the development of chlamydial ocular disease</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>36</volume>: <fpage>1344</fpage>–<lpage>1351</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Peeling1">
        <label>93</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peeling</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Conway</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>AE</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma</article-title>. <source>J Infect Dis</source> <volume>177</volume>: <fpage>256</fpage>–<lpage>259</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Eckert1">
        <label>94</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eckert</surname><given-names>LO</given-names></name>, <name name-style="western"><surname>Hawes</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Wolner-Hanssen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Money</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Peeling</surname><given-names>RW</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease</article-title>. <source>J Infect Dis</source> <volume>175</volume>: <fpage>1453</fpage>–<lpage>1458</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Toye1">
        <label>95</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Toye</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Laferriere</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Claman</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Jessamine</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Peeling</surname><given-names>R</given-names></name> (<year>1993</year>) <article-title>Association between antibody to the chlamydial heat-shock protein and tubal infertility</article-title>. <source>J Infect Dis</source> <volume>168</volume>: <fpage>1236</fpage>–<lpage>1240</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wynn1">
        <label>96</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wynn</surname><given-names>TA</given-names></name> (<year>2004</year>) <article-title>Fibrotic disease and the T(H)1/T(H)2 paradigm</article-title>. <source>Nat Rev Immunol</source> <volume>4</volume>: <fpage>583</fpage>–<lpage>594</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Holland3">
        <label>97</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Conway</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Culley</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Miranpuri</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring</article-title>. <source>Clin Exp Immunol</source> <volume>105</volume>: <fpage>429</fpage>–<lpage>435</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Holland4">
        <label>98</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Jeffries</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pattison</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Korr</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gall</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>51</volume>: <fpage>3893</fpage>–<lpage>3902</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton6">
        <label>99</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Rajak</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Tolbert</surname><given-names>SB</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Conjunctival transcriptome in scarring trachoma</article-title>. <source>Infect Immun</source> <volume>79</volume>: <fpage>499</fpage>–<lpage>511</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Hu2">
        <label>100</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>VH</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Ramadhani</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Tolbert</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Massae</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma</article-title>. <source>Infect Immun</source> <volume>80</volume>: <fpage>121</fpage>–<lpage>130</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Skwor1">
        <label>101</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Skwor</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Atik</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kandel</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Adhikari</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease</article-title>. <source>PLoS Negl Trop Dis</source> <volume>2</volume>: <fpage>e264</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000264" xlink:type="simple">10.1371/journal.pntd.0000264</ext-link></comment></mixed-citation>
      </ref>
      <ref id="pntd.0002020-Natividad2">
        <label>102</label>
        <mixed-citation publication-type="other" xlink:type="simple">Natividad A, Holland M, Mabey D, Bailey R (2010) Expression profiling of cyokines, chemokines and their receptors during human ocular chlamydial infection. Salzburg. pp. 149–152.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton7">
        <label>103</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Ramadhani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Massae</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines</article-title>. <source>Infect Immun</source> <volume>79</volume>: <fpage>4977</fpage>–<lpage>4983</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Kelly1">
        <label>104</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kelly</surname><given-names>KA</given-names></name> (<year>2003</year>) <article-title>Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms</article-title>. <source>Int Rev Immunol</source> <volume>22</volume>: <fpage>3</fpage>–<lpage>41</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Frazer1">
        <label>105</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frazer</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>O'Connell</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Andrews</surname><given-names>CW</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Zurenski</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Darville</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during C. muridarum infection</article-title>. <source>Infect Immun</source> <volume>79</volume> (<issue>10</issue>)  <fpage>4029</fpage>–<lpage>4041</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Roan1">
        <label>106</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roan</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Starnbach</surname><given-names>MN</given-names></name> (<year>2008</year>) <article-title>Immune-mediated control of Chlamydia infection</article-title>. <source>Cell Microbiol</source> <volume>10</volume>: <fpage>9</fpage>–<lpage>19</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Darville2">
        <label>107</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Darville</surname><given-names>T</given-names></name>, <name name-style="western"><surname>O'Neill</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Andrews</surname><given-names>CW</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Nagarajan</surname><given-names>UM</given-names></name>, <name name-style="western"><surname>Stahl</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection</article-title>. <source>J Immunol</source> <volume>171</volume>: <fpage>6187</fpage>–<lpage>6197</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Karimi1">
        <label>108</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karimi</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Ouburg</surname><given-names>S</given-names></name>, <name name-style="western"><surname>de Vries</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Pena</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Pleijster</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>TLR2 haplotypes in the susceptibility to and severity of Chlamydia trachomatis infections in Dutch women</article-title>. <source>Drugs Today (Barc)</source> <volume>45</volume><supplement>Suppl B</supplement>: <fpage>67</fpage>–<lpage>74</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-denHartog1">
        <label>109</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>den Hartog</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Lyons</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Ouburg</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fennema</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>de Vries</surname><given-names>HJ</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>TLR4 in Chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility</article-title>. <source>Drugs Today (Barc)</source> <volume>45</volume><supplement>Suppl B</supplement>: <fpage>75</fpage>–<lpage>82</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Ouburg1">
        <label>110</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ouburg</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lyons</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Land</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>den Hartog</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Fennema</surname><given-names>JS</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection</article-title>. <source>Drugs Today (Barc)</source> <volume>45</volume><supplement>Suppl B</supplement>: <fpage>83</fpage>–<lpage>93</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Hu3">
        <label>111</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>VH</given-names></name>, <name name-style="western"><surname>Massae</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Cree</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Courtright</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>In vivo confocal microscopy of trachoma in relation to normal tarsal conjunctiva</article-title>. <source>Ophthalmol</source> <volume>118</volume> (<issue>4</issue>)  <fpage>747</fpage>–<lpage>754</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Natividad3">
        <label>112</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Natividad</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hull</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Luoni</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rockett</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Innate immunity in ocular Chlamydia trachomatis infection: contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians</article-title>. <source>BMC Med Genet</source> <volume>10</volume>: <fpage>138</fpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Conway1">
        <label>113</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Conway</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Mahdi</surname><given-names>OS</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid</article-title>. <source>Infect Immun</source> <volume>65</volume>: <fpage>1003</fpage>–<lpage>1006</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Natividad4">
        <label>114</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Natividad</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hanchard</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Mahdi</surname><given-names>OS</given-names></name>, <name name-style="western"><surname>Diakite</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians</article-title>. <source>Genes Immun</source> <volume>8</volume>: <fpage>288</fpage>–<lpage>295</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Atik1">
        <label>115</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Atik</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Skwor</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Kandel</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Adhikari</surname><given-names>HK</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Identification of novel single nucleotide polymorphisms in inflammatory genes as risk factors associated with trachomatous trichiasis</article-title>. <source>PLoS ONE</source> <volume>3</volume>: <fpage>e3600</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0003600" xlink:type="simple">10.1371/journal.pone.0003600</ext-link></comment></mixed-citation>
      </ref>
      <ref id="pntd.0002020-Bobo1">
        <label>116</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bobo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Novak</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Mkocha</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Vitale</surname><given-names>S</given-names></name>, <name name-style="western"><surname>West</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma</article-title>. <source>Infect Immun</source> <volume>64</volume>: <fpage>3273</fpage>–<lpage>3279</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton8">
        <label>117</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bowman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Faal</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Aryee</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Ikumapayi</surname><given-names>UN</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Long term outcome of trichiasis surgery in the Gambia</article-title>. <source>Br J Ophthalmol</source> <volume>89</volume>: <fpage>575</fpage>–<lpage>579</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton9">
        <label>118</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>VH</given-names></name>, <name name-style="western"><surname>Massae</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Burr</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Chevallier</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>52</volume>: <fpage>6012</fpage>–<lpage>6017</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Hu4">
        <label>119</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>VH</given-names></name>, <name name-style="western"><surname>Massae</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Chevallier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Onyango</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Bacterial infection in scarring trachoma</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>52</volume>: <fpage>2181</fpage>–<lpage>2186</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Burton10">
        <label>120</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Jeffries</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rajak</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Adegbola</surname><given-names>RA</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>51</volume>: <fpage>3583</fpage>–<lpage>3590</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Onishi1">
        <label>121</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Onishi</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Gaffen</surname><given-names>SL</given-names></name> (<year>2010</year>) <article-title>Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease</article-title>. <source>Immunology</source> <volume>129</volume>: <fpage>311</fpage>–<lpage>321</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Reynolds1">
        <label>122</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reynolds</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Angkasekwinai</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>C</given-names></name> (<year>2010</year>) <article-title>IL-17 family member cytokines: regulation and function in innate immunity</article-title>. <source>Cytokine Growth Factor Rev</source> <volume>21</volume>: <fpage>413</fpage>–<lpage>423</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Khader1">
        <label>123</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khader</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Gaffen</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Kolls</surname><given-names>JK</given-names></name> (<year>2009</year>) <article-title>Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa</article-title>. <source>Mucosal Immunol</source> <volume>2</volume>: <fpage>403</fpage>–<lpage>411</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Torrado1">
        <label>124</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Torrado</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>AM</given-names></name> (<year>2010</year>) <article-title>IL-17 and Th17 cells in tuberculosis</article-title>. <source>Cytokine Growth Factor Rev</source> <volume>21</volume>: <fpage>455</fpage>–<lpage>462</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Kolls1">
        <label>125</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kolls</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Khader</surname><given-names>SA</given-names></name> (<year>2010</year>) <article-title>The role of Th17 cytokines in primary mucosal immunity</article-title>. <source>Cytokine Growth Factor Rev</source> <volume>21</volume>: <fpage>443</fpage>–<lpage>448</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Mi1">
        <label>126</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>HZ</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>JP</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-{beta}1-dependent and -independent mechanisms</article-title>. <source>J Immunol</source> <volume>187</volume>: <fpage>3003</fpage>–<lpage>3014</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Cruz1">
        <label>127</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cruz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fraga</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Fountain</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Rangel-Moreno</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Torrado</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis</article-title>. <source>J Exp Med</source> <volume>207</volume>: <fpage>1609</fpage>–<lpage>1616</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Ramsey5">
        <label>128</label>
        <mixed-citation publication-type="other" xlink:type="simple">Ramsey KH (2006) Alternative mechanisms of pathogenesis. Chlamydia: genomics and pathogenesis. Norfolk, UK: Horizon Bioscience. pp. 435–474.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Hu5">
        <label>129</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Van den Steen</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Sang</surname><given-names>QX</given-names></name>, <name name-style="western"><surname>Opdenakker</surname><given-names>G</given-names></name> (<year>2007</year>) <article-title>Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases</article-title>. <source>Nat Rev Drug Discov</source> <volume>6</volume>: <fpage>480</fpage>–<lpage>498</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Chakrabarti1">
        <label>130</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chakrabarti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>KD</given-names></name> (<year>2005</year>) <article-title>Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology</article-title>. <source>Exp Lung Res</source> <volume>31</volume>: <fpage>599</fpage>–<lpage>621</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wang2">
        <label>131</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>JC</given-names></name> (<year>2005</year>) <article-title>Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia</article-title>. <source>Leuk Lymphoma</source> <volume>46</volume>: <fpage>1261</fpage>–<lpage>1268</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wynn2">
        <label>132</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wynn</surname><given-names>TA</given-names></name> (<year>2008</year>) <article-title>Cellular and molecular mechanisms of fibrosis</article-title>. <source>J Pathol</source> <volume>214</volume>: <fpage>199</fpage>–<lpage>210</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Parks1">
        <label>133</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parks</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Lopez-Boado</surname><given-names>YS</given-names></name> (<year>2004</year>) <article-title>Matrix metalloproteinases as modulators of inflammation and innate immunity</article-title>. <source>Nat Rev Immunol</source> <volume>4</volume>: <fpage>617</fpage>–<lpage>629</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wong1">
        <label>134</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Sethi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Daniels</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Limb</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Matrix metalloproteinases in disease and repair processes in the anterior segment</article-title>. <source>Surv Ophthalmol</source> <volume>47</volume>: <fpage>239</fpage>–<lpage>256</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wong2">
        <label>135</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Mead</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Khaw</surname><given-names>PT</given-names></name> (<year>2005</year>) <article-title>Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>46</volume>: <fpage>2018</fpage>–<lpage>2022</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Imtiaz1">
        <label>136</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Imtiaz</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Distelhorst</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Schripsema</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Sigar</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Kasimos</surname><given-names>JN</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice</article-title>. <source>Microbes Infect</source> <volume>9</volume>: <fpage>1561</fpage>–<lpage>1566</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-ElAsrar1">
        <label>137</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>El-Asrar</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Geboes</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Al-Kharashi</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Al-Mosallam</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Missotten</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Expression of gelatinase B in trachomatous conjunctivitis</article-title>. <source>Br J Ophthalmol</source> <volume>84</volume>: <fpage>85</fpage>–<lpage>91</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Natividad5">
        <label>138</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Natividad</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cooke</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Burton</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Joof</surname><given-names>HM</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection</article-title>. <source>BMC Med Genet</source> <volume>7</volume>: <fpage>40</fpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-AbuElAsrar1">
        <label>139</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abu El-Asrar</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Al-Kharashi</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Missotten</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Geboes</surname><given-names>K</given-names></name> (<year>2006</year>) <article-title>Expression of growth factors in the conjunctiva from patients with active trachoma</article-title>. <source>Eye</source> <volume>20</volume>: <fpage>362</fpage>–<lpage>369</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Thylefors1">
        <label>140</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thylefors</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Negrel</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Pararajasegaram</surname><given-names>R</given-names></name> (<year>1992</year>) <article-title>[Epidemiological surveillance of trachoma: evaluation and perspective]</article-title>. <source>Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique</source> <volume>69</volume>: <fpage>107</fpage>–<lpage>114</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Leach1">
        <label>141</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leach</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Shelby-James</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Mayo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gratten</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Laming</surname><given-names>AC</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae</article-title>. <source>Clin Infect Dis</source> <volume>24</volume>: <fpage>356</fpage>–<lpage>362</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Brunham2">
        <label>142</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brunham</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Rekart</surname><given-names>ML</given-names></name> (<year>2008</year>) <article-title>The arrested immunity hypothesis and the epidemiology of chlamydia control</article-title>. <source>Sex Transm Dis</source> <volume>35</volume>: <fpage>53</fpage>–<lpage>54</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Woodall1">
        <label>143</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woodall</surname><given-names>JP</given-names></name> (<year>2003</year>) <article-title>Proceedings of the Chlamydia Vaccine Development Colloquim</article-title>. <source>The Albert B Sabin Vaccine Institute</source></mixed-citation>
      </ref>
      <ref id="pntd.0002020-Frick1">
        <label>144</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frick</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Colchero</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Dean</surname><given-names>D</given-names></name> (<year>2004</year>) <article-title>Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis</article-title>. <source>Vaccine</source> <volume>22</volume>: <fpage>689</fpage>–<lpage>696</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Grayston2">
        <label>145</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grayston</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Woolridge</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Yen</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>CY</given-names></name>, <etal>et al</etal>. (<year>1963</year>) <article-title>Field studies of protection from infection by experimental trachoma virus vaccine in preschool-aged children on Taiwan</article-title>. <source>Proc Soc Exp Biol Med</source> <volume>112</volume>: <fpage>589</fpage>–<lpage>595</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Grayston3">
        <label>146</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grayston</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Woolridge</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Alexander</surname><given-names>ER</given-names></name> (<year>1964</year>) <article-title>Prevention of trachoma with vaccine</article-title>. <source>Arch Environ Health</source> <volume>8</volume>: <fpage>518</fpage>–<lpage>526</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Nichols2">
        <label>147</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nichols</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>SD</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Murray</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Haddad</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Bobb</surname><given-names>AA</given-names></name> (<year>1966</year>) <article-title>Studies on trachoma. V. Clinical observations in a field trial of bivalent trachoma vaccine at three dosage levels in Saudi Arabia</article-title>. <source>Am J Trop Med Hyg</source> <volume>15</volume>: <fpage>639</fpage>–<lpage>647</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Clements1">
        <label>148</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Clements</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dhir</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Grayston</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>SP</given-names></name> (<year>1979</year>) <article-title>Long term follow-up study of a trachoma vaccine trial in villages of Northern India</article-title>. <source>Am J Ophthalmol</source> <volume>87</volume>: <fpage>350</fpage>–<lpage>353</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Kari1">
        <label>149</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kari</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Whitmire</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Olivares-Zavaleta</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Goheen</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>LD</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates</article-title>. <source>J Exp Med</source> <volume>208</volume>: <fpage>2217</fpage>–<lpage>2223</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wang3">
        <label>150</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kahane</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cutcliffe</surname><given-names>LT</given-names></name>, <name name-style="western"><surname>Skilton</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Lambden</surname><given-names>PR</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector</article-title>. <source>PLoS Pathog</source> <volume>7</volume>: <fpage>e1002258</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1002258" xlink:type="simple">10.1371/journal.ppat.1002258</ext-link></comment></mixed-citation>
      </ref>
      <ref id="pntd.0002020-Wolle2">
        <label>151</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolle</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mkocha</surname><given-names>H</given-names></name>, <name name-style="western"><surname>West</surname><given-names>SK</given-names></name> (<year>2009</year>) <article-title>Age, sex, and cohort effects in a longitudinal study of trachomatous scarring</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>50</volume>: <fpage>592</fpage>–<lpage>596</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Bowman1">
        <label>152</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bowman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Jatta</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cham</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Faal</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Natural history of trachomatous scarring in The Gambia: results of a 12-year longitudinal follow-up</article-title>. <source>Ophthalmology</source> <volume>108</volume>: <fpage>2219</fpage>–<lpage>2224</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Bowman2">
        <label>153</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bowman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Faal</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Myatt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Adegbola</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Longitudinal study of trachomatous trichiasis in the Gambia</article-title>. <source>Br J Ophthalmol</source> <volume>86</volume>: <fpage>339</fpage>–<lpage>343</lpage>.</mixed-citation>
      </ref>
      <ref id="pntd.0002020-Munoz2">
        <label>154</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Munoz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Aron</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>V</given-names></name>, <name name-style="western"><surname>West</surname><given-names>S</given-names></name> (<year>1997</year>) <article-title>Incidence estimates of late stages of trachoma among women in a hyperendemic area of central Tanzania</article-title>. <source>Trop Med Int Health</source> <volume>2</volume>: <fpage>1030</fpage>–<lpage>1038</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>